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Take home message We report a systematic review that identifies factors associated with the optimal initiation and ongoing monitoring of NIV in patients with ALS┻ We make recommendations to optimise the use of NIV in ALS to improve patient outcomes┻ 
 
 
Abstract Background Non┽invasive ventilation ゅNIVょ prolongs survival and quality of life in amyotrophic lateral sclerosis ゅALSょ┹ however┸ its benefits depend upon the optimisation of both ventilation and adherence┻ We aimed to identify factors associated with effective initiation and ongoing use of NIV in ALS to develop evidence┽based guidance and identify areas for further research┻  Methods We searched eleven electronic databases ゅJan なひひぱ ‒ May にどなぱょ for all types of quantitative and qualitative studies┻ Supplementary grey literature searches were conducted┻ Records were screened against eligibility criteria┸ data were extracted from included studies and risk of bias was assessed┻ We present findings using a narrative synthesis┻ Results We screened にねぬど unique records and included のに quantitative and は qualitative papers┻ Factors reported to be associated with NIV optimisation included┺ co┽ordinated multidisciplinary care┸ place of initiation┸ selection of interfaces┸ ventilator modes and settings appropriate for the individual patient┸ and adequate secretion management┻ The literature indicated that patients with significant bulbar dysfunction can still derive considerable benefit from NIV if their needs are met┻ Research emphasises that obstructive airway events┸ mask leak and uncontrolled secretions should be addressed by adjustments to the interface and machine settings┸ and the concomitant use of cough augmentation┻ Conclusion This review highlights that NIV optimisation requires an individualised approach to respiratory management tailored to the differing needs of each patient┻ Ultimately this should lead to improved survival and quality of life┻ This review expands on recommendations in current international guidelines for NIV use in ALS and identifies areas for future research┻  
 
 
Background In patients with amyotrophic lateral sclerosis ゅALSょ【motor neuron disease ゅMNDょ┸ hypoventilatory respiratory failure is the most common cause of death and respiratory morbidity is related to a poorer quality of life ゅなょ┻ Non┽invasive ventilation ゅNIVょ improves survival and quality of life for patients with ALS in respiratory failure by up to なぱ months ゅに┸ ぬょ┻ However┸ the success of NIV is related to its optimisation┺ the quality ゅventilationょ and quantity ゅadherenceょ of NIV received are prognostic factors in ALS ゅねょ┻ If ventilation is not optimised the benefits are dramatically reduced┺ the one┽year survival was ばのガ in ALS patients experiencing good correction of hypoxia on NIV┸ reducing to ねぬガ in the absence of good correction ゅねょ┻ Therefore┸ the effectiveness of ventilation needs to be monitored┸ with adjustments made to address any issues and compensate for further disease progression┻ Adherence must also be optimised┻ Patients who could tolerate NIV for four hours per day demonstrated improved survival post┽NIV initiation ゅなね┻に monthsょ relative to those who used it for less than four hours per day ゅば┻ど months┸ pサど┻どどにょ or those who declined NIV ゅね┻は months┸ pジど┻どどなょ ゅのょ┻  NIV is a complex intervention ゅはょ┸ the success of which is influenced by the interaction of multiple service┸ equipment┸ patient and carer factors┻ These may include┺ the service delivery model and process of NIV initiation┹ the choice of mask interface┸ ventilator mode and machine settings┹ and the presence of significant bulbar dysfunction┻ Guidelines from the National Institute for Health and Care Excellence ゅNICEょ ゅばょ┸ European Federation of Neurological Societies ゅEFNSょ ゅぱょ and American Academy of Neurology ゅAANょ ゅひょ for the management of NIV in ALS reflect the lack of evidence on how best to address these factors and┸ consequently┸ practice varies between services ゅなどょ┻ The aim of this systematic review was to identify factors associated with optimal NIV initiation and ongoing adherence and ventilation in ALS to develop evidence┽based guidance and identify areas for further research┻  Methods Protocol The review protocol was registered with the PROSPERO database ゅCRDねにどなぱどひねぬひねょ and was conducted in accordance with PRISMA reporting standards ゅsee Appendix なょ ゅななょ┻  Search strategy Eleven electronic databases were searched ゅfrom Jan なひひぱ ‒ May にどなぱ┸ except where statedょ┺ MEDLINE via OvidSP┸ MEDLINE In┽Process ┃ Other Non┽Indexed Citations ┃ Epub Ahead of Print ┃ MEDLINE ｋ without Revisions via OvidSP┸ EMBASE via OvidSP┸ CINAHL via EBSCO┸ PsycINFO via OvidSP┸ Cochrane Database of Systematic Reviews via The Cochrane Library ゅにどどの ‒ May にどなぱょ┸ Database of Abstracts of Reviews of Effects via The Cochrane Library ゅなひひぱ ‒ April にどなの┹ archive onlyょ┸ Cochrane Central Register of Controlled Trials ゅCENTRALょ via The Cochrane Library┸ Health Technology Assessment Database via The Cochrane Library┸ Science Citation Index via Web of Science and Social Sciences Citation Index via Web of Science┻  Supplementary searching techniques included handsearching of included studies╆ reference lists and grey literature searches using OpenGrey and websites of relevant organisations┸ including those of the Motor Neurone Disease Association ゅhttps┺【【www┻mndassociation┻orgょ┸ NICE ゅhttps┺【【www┻nice┻org┻ukょ and NHS Evidence ゅhttps┺【【www┻evidence┻nhs┻ukょ┻  
 
 
Search terms involved a combination of MeSH subject headings ゅe┻g┻ Motor Neuron Disease┸ Noninvasive Ventilation┸ Artificial Respirationょ and free┽text terms ゅe┻g┻ ALS┸ NIV┸ respiratory failureょ┸ with the search strategy developed and led by an information specialist┻ Searches were limited to humans and English language┻ The search strategy for MEDLINE is provided in Appendix に┻ Study selection Citations retrieved from electronic database searches were uploaded to EndNote ゅVersion ばょ┻ Titles and abstracts were independently screened by two reviewers against the eligibility criteria ゅsee Table なょ┹ a third reviewer resolved any uncertainties┻ The level of agreement between the two reviewers regarding study inclusion was over ひのガ┻ Full texts were then obtained┻   
Table な┻ Study eligibility criteria 
Criterion Eligibility criteria 
Population Studies in patients with a diagnosis of ALS【MND┸ or their families and caregivers┸ or healthcare professionals involved in their care┻ 
Intervention Studies involving any form of long┽term┸ domiciliary NIV┸ defined as ventilatory support administered via a removable mask【mouthpiece┻  
Comparator Studies with comparator and non┽comparator designs┻ 
Outcome Studies reporting any outcome related to the optimisation of NIV initiation┸ monitoring and ongoing care ゅe┻g┻ oxygen and carbon dioxide saturations┸ patient adherence and quality of life metricsょ┻ 
Study design Empirical quantitativeこ and qualitative studies published in English in the last にど years┻ここ ALS┸ amyotrophic lateral sclerosis┹ MND┸ motor neuron disease┹ NIV┸ non┽invasive ventilation こ A range of quantitative studies were eligible┸ including randomised controlled trials and other experimental designs┹ prospective┸ retrospective and cross┽sectional observational studies┹ and┸ case studies┻  ここ The review was restricted to studies published in the last にど years to ensure findings are relevant to current practice and given potential changes in prognosis during this timeframe┻  Data extraction Data were extracted from included studies using a pre┽piloted extraction form┻ We collected data on┺ first author┸ publication year┸ study design┸ sample size┸ population characteristics┸ data collection method┸ outcome measures┸ intervention characteristics┸ theoretical underpinning┸ summary of results and main author conclusions┻ The form was suitable for all types of quantitative study designs and was modified for qualitative studies┻ Extraction forms for each study were completed by one reviewer and verified by a second┸ as is recommended as an accepted minimum ゅなにょ┻ Multiple citations from a single study were brought together into a single extraction where possible┸ to avoid double┽counting data┻  
 
 
Risk of bias assessment We assessed the risk of bias using the established hierarchy of evidence and checklists for each study type┸ where appropriate┻ For controlled studies┸ we considered sources of potential bias as recommended by Cochrane ゅなぬょ┻ For other quantitative studies┸ we used the National Institutes of Health checklists ゅなねょ┻ For qualitative studies┸ the Critical Appraisals Skills Programme checklist was used ゅなのょ┻ Due to significant between┽study heterogeneity┸ risk of bias was not assessed across the cumulative evidence┻ Synthesis Study heterogeneity precluded the use of a meta┽analysis┻ Quantitative data were synthesised using a narrative synthesis method┻ Themes reported in qualitative studies were integrated where they related to the quantitative findings┻ We brought together studies examining similar processes or reporting similar outcomes┸ identifying where data agreed and where it conflicted┸ and provide an indication of the volume and quality of the evidence┻  
 Results Study selection Of にねぬど records screened┸ ににな documents were assessed at full┽text level for eligibility┸ and のぱ studies ゅのに quantitative and は qualitativeょ were included in the review ゅsee Figure なょ┻  Study characteristics The included studies involved a range of な ‒ ねばね participants ゅmean┺ ばど┻はひょ┻ Five studies used an experimental design┺ two randomised controlled trials ゅRCTょ ゅぬ┸ なはょ┸ two randomised crossover studies ゅなば┸ なぱょ and one quasi┽randomised controlled trial ゅなひょ┻ The remaining quantitative studies were observational┺ なぬ prospective┸ なは retrospective┸ seven cross┽sectional and なな case studies┻ Six qualitative studies were also included┻ See Appendix ぬ for the characteristics of included studies┻ The included RCTs were found to be at a low risk of bias┸ while the other three experimental designs had a higher risk of bias┸ due to issues including┺ unclear random allocation method and reporting bias┻ The observational studies were all considered to be at higher risk of bias┸ although some provided more robust evidence than others┹ for example┸ seven included studies used a prospective design with sample size greater than ぬど and adequate control for confounding variables ゅにど‒にはょ┻ Completed quality assessments for individual studies are available as Appendix ね┻        
 
 
Figure な┻ PRISMA flow chart illustrating the study selection process                              こ The majority of those excluded on study design were conference abstracts ゅnサぱどょ for which no full text could be obtained┻  
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Service factors that influence NIV optimisation 
Service delivery model Eight studies investigated the effects of a multidisciplinary team approach to ALS care on NIV usage┺ one prospective ゅにばょ┸ one retrospective ゅにぱょ and six cross┽sectional studies ゅにひ‒ぬねょ┻ Evidence was found in all for a positive effect of multidisciplinary care on outcomes related to NIV usage┸ including access to NIV┸ patient acceptance and adherence┻ A prospective Italian study in ぬば patients evaluated a complex intervention during the initial adaptation to NIV┸ involving a patient education session┸ intensive inpatient monitoring┸ and follow┽up with adjustments made as necessary ゅにばょ┻ Adherence above four hours per night was achieved in all ぬば patients at discharge after a mean inpatient stay of なに グに days┻ At one┽year┸ ぬの of ぬば ゅひのガょ patients remained NIV┽adherent┻ A retrospective before┽and┽after study in ばば participants observed an increase in NIV acceptance following the addition of a respiratory therapist to the ALS clinic ゅのねガ to ぱにガ┸ pサど┻どどばょ ゅにぱょ┻ Adherence above four hours per day also increased ゅににガ to ばぬガ┸ pサど┻どにばょ┻ Both studies failed to adequately control for confounding variables┻ In an epidemiological study of にのひ patients in Italy┸ NIV was more frequently initiated within tertiary ALS centres than general neurology clinics from なひひの‒にどどね ゅぬば┻にガ vs┻ ぱ┻ぱガ┸ pサど┻どどどなょ ゅにひょ┻ Seventy┽six Italian respiratory centres were surveyed in another study┺ ひどガ used a multidisciplinary approach┸ involving close co┽operation between respiratory and neurology physicians┸ physiotherapists and psychologists ゅぬなょ┻ High┽referring centres more frequently reported good collaboration with neurologists than low┽referring centres ゅねのガ vs┻ にぬガ┸ pサど┻どねょ┻ Response rates below のどガ increase the risk of bias here┻ A survey of なな Canadian ALS specialists cited effective co┽ordination between respiratory and neurology services and the availability of respiratory specialists as contributors to good NIV adherence ゅぬどょ┻ A UK audit described the utility of joint respiratory and palliative multidisciplinary clinics for monitoring respiratory function┸ commencing NIV and discussing end┽of┽life care in six patients ゅぬねょ┻  
Place of initiation Five studies examined the effects of place of NIV initiation┺ one RCT ゅなはょ┸ one prospective before┽and┽after study ゅにはょ┸ two cross┽sectional studies ゅぬね┸ ぬのょ and one qualitative study ゅぬはょ┻ Two studies evaluated a day case ゅoutpatientょ model of initiation ゅなは┸ にはょ┻ An Italian RCT compared initiation as a day case ゅnサにのょ versus an overnight inpatient ゅnサにのょ ゅなはょ┻ Similar rates of NIV adherence were observed during initiation ゅばはガ vs┻ ぱどガ┸ pサど┻ばぬぬょ and at three months ゅはぱガ vs┻ ばはガ┸ pサど┻のにひょ┻ Patient and healthcare professional satisfaction┸ respiratory function changes and symptom control were similar in both groups┻ An Australian centre compared a multi┽day inpatient initiation ゅnサなばょ to a day case initiation ゅnサなにょ in a prospective before┽and┽after study ゅにはょ┻ ╅Suitable patients╆ were initiated as outpatients┸ highlighting a possible selection bias┻ Median waiting time for NIV initiation fell from ぬど to なぬ┻の days ゅpジど┻どねょ┸ and adverse events ゅdeath or acute admission with respiratory failureょ declined from four out of なば ゅにねガょ to ど out of なに ゅどガょ┸ while daytime arterial COに levels were equivalent┻ Median post┽initiation survival was extended from にばぱ to のぱど days ゅhazard ratio┺ ど┻ねな┸ pサど┻どねょ┻ An international survey of なぱは ALS clinicians found that patients are admitted to hospital for initiation more often in Europe than the USA ゅなは【ぬひ いねな┻どガう vs┻ ど【のば いどガう┸ pジど┻どどなょ ゅぬのょ┻ However┸ a UK audit described successful home initiation in six patients with the support of a specialist respiratory nurse ゅぬねょ┻ A qualitative study reported patient anxiety regarding hospital admission┹ this was a major barrier for one patient who eventually accepted a trial of NIV as a day case ゅぬはょ┻ 
 
 
 Equipment factors that influence NIV optimisation 
Interface Sixteen studies examined the effect of the interface on NIV optimisation┺ one RCT ゅぬょ┸ one randomised crossover trial ゅなぱょ┸ three prospective cohorts ゅにに┸ ぬば┸ ぬぱょ┸ four retrospective cohorts ゅね┸ ぬひ‒ねなょ┸ one cross┽sectional survey ゅぬどょ┸ four case reports ゅねに‒ねのょ and two qualitative studies ゅねは┸ ねばょ┻ Interface intolerance was associated with poor adherence in two prospective studies ゅにに┸ ぬばょ┸ one cross┽sectional ゅぬどょ and one case report ゅねねょ┻ Commonly reported problems in two qualitative studies included reluctance to use the mask in company┸ interference with eating and communication┸ pressure sores┸ dry mouth┸ mask leak and claustrophobia┸ which may contribute to poor adherence ゅねは┸ ねばょ┻ Six studies identified interface┽related causes for ineffective ventilation┺ mask leak in four studies ゅね┸ なぱ┸ ぬぱ┸ ねなょ and obstructive sleep apnoea ゅOSAょ in two ゅぬひ┸ ねにょ┻ A retrospective analysis identified mask leak as a leading source of persistent nocturnal desaturations in のぬガ of cases in ぱに patients studied ゅねょ┻ Optimisation of mask fitting successfully minimised leak in this study and a case report ゅね┸ ねのょ┻ In a retrospective cohort┸ NIV┽associated OSA was present in なひ of ひぬ ゅにど┻ねガょ patients using oronasal masks ゅぬひょ┻ A case report also described OSA induced by an oronasal mask ゅねにょ┻ Both studies reported changing to a nasal mask with a chin strap to eliminate obstructive events┻ One higher┽quality RCT ゅぬょ┸ one retrospective cohort ゅねどょ and a case report ゅねぬょ highlighted the value of daytime mouthpiece ventilation┸ which facilitates adjuvant cough augmentation to expectorate secretions┸ although this requires adequate bulbar function ゅぬ┸ ねど┸ ねぬょ┻   
Ventilator type┸ mode and settings Eighteen studies assessed the effect of ventilator type┸ mode or settings on NIV optimisation┺ one randomised crossover trial ゅなばょ┸ two prospective ゅぬば┸ ぬぱょ┸ six retrospective ゅに┸ ね┸ ぬひ┸ ねな┸ ねぱ┸ ねひょ┸ six case reports ゅねに┸ ねの┸ のど‒のぬょ and three qualitative studies ゅねは┸ のね┸ ののょ┻ A retrospective multicentre cohort with adequate control for confounding variables reported effective ventilation at one┽month in ねの of はに ゅばに┻はガょ patients using volume┽preset ゅVol┽NIVょ systems compared with ねど of ぱに ゅねぱ┻ぱガょ patients using pressure┽preset ゅPres┽NIVょ systems ゅpジど┻どどなょ ゅにょ┻ However┸ there were no survival differences between the two groups ゅpサど┻のぬぬょ┻ In a retrospective study of にばな patients┸ average volume┽assured pressure support ゅAVAPSょ ventilation produced greater average tidal volumes than Pres┽NIV ゅぬひど vs┻ ぬのはmL┸ pサど┻どどばょ with similar usage ゅは┻の vs┻ は┻はh【day┸ pサど┻ばどぬょ ゅねひょ┻ These findings are limited by the possibility of selection bias and the use of surrogate outcomes for ventilation ゅlung volumesょ rather than alveolar gases┻ Three studies reported the effects of switching from Pres┽NIV to Vol┽NIV or vice┽versa┻ Switching from Pres┽NIV to Vol┽NIV resolved OSA in one patient in a large retrospective study ゅねぱょ and improved ventilation in another case ゅねねょ┻ A case series described a switch from Vol┽NIV to Pres┽NIV ゅin the case of increased leakょ and vice┽versa ゅin the case of increased secretionsょ┸ which corrected hypoxia and hypercapnia┸ and improved symptoms┸ respectively ゅのなょ┻   The need to make decisions on a case┽by┽case basis was also demonstrated in a randomised crossover trial of spontaneous ゅSょ and spontaneous【timed ゅSTょ NIV modes in なぬ patients ゅなばょ┻ The ST mode provided more effective ventilation overall in terms of mean overnight oxygen saturations ゅぱばガ vs┻ ぱぬガ┸ pジど┻どのょ and time spent with an overnight transcutaneous COに スのの mmHg ゅどガ vs┻ にどガ┸ pジど┻どのょ┹ however┸ four patients ゅwho could not be predicted from baseline characteristicsょ displayed better ventilation outcomes on the S mode┻ Survival effects were not assessed┸ while the risk of bias was considered high due to the small sample size and non┽
 
 
reporting of randomisation processes┻  Two prospective studies from the same centre described intolerance of the ST mode in seven out of ぬの ゅにどガょ patients ゅfive with bulbar involvementょ ゅぬばょ and six out of にに ゅにばガょ patients ゅfour with bulbar involvementょ ゅぬぱょ┸ respectively┸ which improved upon switching to the S mode in all cases┻   Low┽quality evidence from three case reports suggested poor NIV adherence due to air┽swallowing ゅのぬょ┸ excessively high airway pressures on Pres┽NIV machines ゅのどょ and target tidal volumes on Vol┽NIV systems ゅねのょ┻ In the latter case┸ adherence improved when target tidal volumes were reduced from ぱml【kg to はml【kg┻ Three qualitative studies linked discomfort associated with air pressure to reduced adherence ゅねは┸ のね┸ ののょ┻ Conversely┸ insufficient ventilation settings were associated with poor ventilation in ぬね┻ばガ patients in one retrospective study ゅねなょ┻ Three studies reported the benefit of increasing ventilator support to improve ventilation┸ by increasing inspiratory positive airway pressure ゅIPAPょ in a retrospective cohort ゅねょ and case report ゅねのょ and increasing target tidal volumes in another case report ゅのなょ┻ Increasing expiratory positive airway pressure ゅEPAPょ helped to eliminate OSA in three retrospective studies ゅね┸ ぬひ┸ ねぱょ┻ Other successful measures found to improve ventilation are reported in Table に┻  A flow chart summary can be found in Appendix の┻   
Table に┻ Troubleshooting┺ NIV problems and solutions 
Problem Solution Level of evidence 
Obstructive airway 
events 
Increase EPAP Three retrospective studies ゅね┸ ぬひ┸ ねぱょ Switch to an auto┽titrating mode of NIV Two retrospective studies ゅぬひ┸ ねぱょ Switch from an oronasal mask to a nasal mask with a chin strap One retrospective study ゅぬひょ and one case report ゅねにょ  Reduce inspiratory time and reduce IPAP One case report ゅねにょ 
 Switch from Pres┽NIV to Vol┽NIV One retrospective study ゅねぱょ 
Mask leak Optimise mask fitting One retrospective study ゅねょ and one case report ゅねのょ  
 Switch from Vol┽NIV to Pres┽NIV One case report ゅのなょ 
Hypoventilation Increase IPAP ゅPres┽NIV machinesょ One retrospective study ゅねょ and one case report ゅねのょ  Increase target tidal volumes ゅVol┽NIV machinesょ One case report ゅのなょ 






Trial an increase in minimum inspiratory timeこ One case report ゅのにょ 
Excess respiratory 
secretions 
Use adjuvant cough┽assist devices    Switch from Pres┽NIV to Vol┽NIV 
Three retrospective studies ゅのは‒のぱょ and two case reports ゅねぬ┸ ねねょ  One case report ゅのなょ 
Excess oropharyngeal 
secretions 
Subcutaneous glycopyrrolate infusion One case report ゅのひょ 
EPAP┸ expiratory positive airway pressure┹ IPAP┸ inspiratory positive airway pressure┹ Pres┽NIV┸ pressure┽preset non┽invasive ventilation┹ Vol┽NIV┸ volume┽preset non┽invasive ventilation こ Only after first ensuring that the mask and tubing are free from condensation┸ that unintentional leak is minimised┸ and that appropriate trigger and cycle sensitivities are set┻ Minimum inspiratory times may not be adaptable on some ventilators┻   
Adjuvant therapies Seven studies described the use of adjuvant interventions┺ two prospective ゅにば┸ はどょ┸ two retrospective ゅねぱ┸ はなょ and three case studies ゅねね┸ のど┸ はにょ┻ Music┽assisted relaxation was beneficial in supporting NIV transition within the first week in a prospective feasibility study of なの patients ゅはどょ┹ however┸ risk of bias was deemed high due to methodological flaws in participant selection┸ outcome measurement and statistical analysis┻ Successful use of a portable hand┽held ventilator ゅPhilips ╅Vitabreath╆ょ in three patients was reported in a case series┸ although the authors indicated that patients may struggle with the pressure differences compared to their usual ventilators ゅはにょ┻ Two studies examined the use of  mandibular advancement devices in treating OSA and improving NIV adherence┺ one case report described its successful use ゅのどょ while a retrospective study found no benefit ゅねぱょ┻   Secretion management Nine studies examined the impact of controlling secretions on NIV optimisation┺ two prospective ゅにね┸ にばょ┸ three retrospective ゅのは‒のぱょ┸ three case reports ゅねぬ┸ ねね┸ のひょ and one qualitative study ゅねはょ┻ An association between excess oropharyngeal or airway secretions and poor adherence was found in two prospective studies ゅにね┸ にばょ and one case report ゅのひょ┻ One prospective study found that an absence of airway secretions was predictive of good adherence ゅodds ratio┺ なな┻の いな┻ぬ‒ひぱ┻ねうょ┸ while the case report described an improvement in NIV usage ゅfrom ジなh to は‒ぱh【nightょ following treatment with a subcutaneous glycopyrrolate infusion ゅのひょ┻  Five studies highlighted the role of cough augmentation in the active management of secretions┺ three retrospective studies ゅのは‒のぱょ and two case reports ゅねぬ┸ ねねょ┻ A retrospective analysis of ねばね patients found a significant improvement in survival between NIV users who also used daily cough┽assist compared to those using NIV alone ゅmedian┺ にの┻ばぬ months vs┻ なの┻どど months┸ pジど┻どどなょ ゅのぱょ┻ Combined use of NIV and cough┽assist was successful in avoiding tracheostomy in 
 
 
two retrospective studies of などな patients each ゅのは┸ のばょ and resolving ねぬ out of ばぱ ゅののガょ desaturation episodes ゅのばょ┻   Efficacy monitoring  
Monitoring ventilation Two retrospective studies reported that effective ventilation predicted survival ゅね┸ ねぱょ┸ while another retrospective study did not find the effectiveness of NIV to be a prognostic factor ゅにょ┻ In one study┸ only ねど of ぱに ゅねひガょ patients were effectively ventilated at one┽month ゅねょ┻ Importantly┸ one┽year survival was ばのガ in those effectively ventilated at one┽month┸ declining to ねぬガ in those ineffectively ventilated ゅpサど┻どどにょ┻ Remedial measures at one┽ and three┽months corrected ventilation by month six in なに ゅねぬガょ patients and one┽year mortality in this subgroup was similar to those effectively ventilated at one┽month ゅfour deaths vs┻ three┸ pサど┻なぬょ┻ In なは ゅのばガょ patients NIV was still inadequate at month six despite corrective measures┻ One┽year mortality in this subgroup was significantly higher than in those effectively ventilated at one┽month ゅseven deaths vs┻ three┸ pサど┻どどにょ┻ Another study found ineffective ventilation in ばぬ of なばひ ゅねなガょ patients at one┽month┸ due to OSA in ねひ cases ゅはばガょ ゅねぱょ┻ Individuals adequately ventilated at one┽month┸ and those for whom OSA was successfully eliminated within the first month┸ experienced greater median survival ゅには いなぬ‒ねのう months and にひ いにど‒のぬう months┸ respectivelyょ than those who were inadequately ventilated at one┽month due to uncorrected obstructive events ゅなね いば‒にばう months┸ pジど┻どのょ or other causes ゅなに いは‒にぬう months┸ pジど┻どのょ┻  Two retrospective studies investigated the need for longitudinal adaptations to machine settings with disease progression ゅに┸ はなょ┻ Twenty┽eight out of ぬは ゅばぱガょ patients required at least one upward change in pressure settings ゅはなょ┻ In a two┽centre comparison┸ ventilator setting changes were required more frequently in ぱに patients using pressure┽preset ゅPres┽NIVょ than はに using volume┽preset ゅVol┽NIVょ machines┺ のなガ vs┻ なねガ ゅpジど┻どどなょ ゅにょ┻ Of those ineffectively ventilated in the first month┸ effective ventilation was achieved after the first modification in ばひガ of the Vol┽NIV group and ぬなガ of the Pres┽NIV group ゅpジど┻どどなょ┻ 
Monitoring adherence Survival correlated with hours of NIV use in three papers┺ one prospective cohort ゅになょ and two retrospective cohorts ゅの┸ のぱょ┻ Seventeen studies reported NIV adherence rates┺ nine prospective ゅにど‒にね┸ にば┸ ぬば┸ ぬぱ┸ はぬょ┸ seven retrospective ゅに┸ ね┸ にぱ┸ ねぱ┸ ねひ┸ はな┸ はねょ and one cross┽sectional study ゅにひょ┻ The proportion of patients achieving at least four hours of use per day ranged from ねは‒などどガ┻  
Telemonitoring The costs of a home telemonitoring system were analysed in a quasi┽randomised controlled trial of ぬひ patients┸ observing a ののガ reduction in average total costs in patients with the telemonitoring system ゅｑぱひどぱ┻は グ はののに┻ばょ versus those on standard care ゅｑなひははね┻ひ グ のにのは┻のょ due to reduced healthcare utilisation ゅなひょ┻ However┸ this reduction did not reach statistical significance ゅpサど┻どのぱょ┻ The impact of the telemonitoring system on NIV efficacy or survival was not assessed┻ This trial was judged to be at high risk of bias due to a non┽random allocation method and potential reporting bias┻  
 
 
 Patient and carer factors that influence NIV optimisation 
Bulbar dysfunction Twenty┽three studies investigated the effects of bulbar impairment on NIV optimisation┺ two RCTs ゅぬ┸ なはょ┸ ten prospective cohorts ゅにど‒にの┸ ぬば┸ ぬぱ┸ はぬ┸ はのょ┸ six retrospective cohorts ゅねど┸ のは‒のぱ┸ はね┸ ははょ┸ two cross┽sectional studies ゅにひ┸ ぬどょ and three case reports ゅねぬ┸ ねね┸ はばょ┻ Nineteen studies found an association between bulbar impairment and poorer adherence or ventilation┸ while four studies ゅincluding one RCTょ identified no such association┻ In this RCT┸ bulbar┽onset disease predicted greater NIV adherence ゅなはょ┹ however┸ another RCT reported an average use per day of ひ┻ぬ hours in the more preserved bulbar function subgroup versus ぬ┻ぱ hours in those with poor bulbar function ゅぬょ┻ In two prospective studies of ばな and ばぬ participants with adequate control for confounding variables┸ those with more severe bulbar impairment had an increased risk of poor adherence┺ six┽fold in one ゅodds ratio┺ は┻どひ いな┻なぱ┸ ぬな┻のにうょ ゅになょ and eight┽fold in another ゅodds ratio┺ ぱ┻の いな┻は┸ ねは┻にうょ ゅにねょ┻ In the latter trial┸ bulbar┽predominant patients were reported to need more intensive and prolonged monitoring at NIV onset to maximise adherence ゅにねょ┻ In spite of this┸ one prospective cohort reported one┽year adherence above four hours per day in ぬの out of ぬば ゅひのガょ patients who had undergone an intensive education and adaptation programme at initiation despite nine presenting severe bulbar involvement at initiation and にぬ mild┽moderate impairment ゅにばょ┻  Eighteen studies investigated survival or quality of life outcomes in patients with bulbar dysfunction using NIV┻ Fourteen studies found that bulbar patients derived some benefit from NIV┺ two RCTs ゅぬ┸ なはょ┸ six prospective ゅにど┸ にな┸ にば┸ ぬば┸ ぬぱ┸ はのょ┸ five retrospective ゅの┸ ねな┸ のぱ┸ はね┸ はぱょ and one cross┽sectional study ゅにひょ┻ Four studies reported no benefit┺ three retrospective ゅねど┸ のは┸ のばょ and one case study ゅはばょ┻ Generally┸ the gains derived in bulbar patients were reduced compared with non┽bulbar patients┸ as reflected in an RCT where a subgroup with poorer bulbar function experienced no survival gain despite some quality of life benefits ゅぬょ┻ However┸ the trial was not powered for this subgroup analysis┻ Perhaps surprisingly┸ one retrospective study observed a median survival benefit from NIV of なぬ months in all になひ patients┸ increasing to なひ months in のぱ with bulbar┽onset disease ゅはぱょ┻ 
Patient and carer perceptions The effect of patient and carer perceptions on the optimisation of NIV was examined in four qualitative studies┸ involving between five and ぬば participants ゅねは┸ ねば┸ のね┸ はひょ┻ Adaptation to NIV takes time for many patients┸ beginning with familiarisation with the equipment ゅはひょ┻ Some patients highlighted the importance of an initial trial period to gauge the positive effects of NIV ゅはひょ┻ Determination and perseverance were required to optimise adherence┸ while accessible in┽person or telephone support might be beneficial in overcoming early obstacles ゅねはょ┻ Carers reported a lack of confidence in adjusting the machine ゅねはょ┸ which lessened with increased familiarity ゅねばょ┻ Sleep disturbance may occur in patients and carers due to the machine noise and having to make adjustments to the system ゅねは┸ のねょ┻ A positive coping style and perceived need to engage with the treatment was related to better adherence┸ while feelings of hopelessness were associated with poor adherence ゅのねょ┻ Hopelessness was observed to be modifiable and improvements positively influenced patients╆ attitudes to NIV┻  
 
 
Discussion  This review has highlighted the importance of optimising both adherence and ventilation to gain the full benefit from NIV for patients with ALS┻ Patients must receive effective routine services┸ which should also be highly adaptable and co┽ordinated to support the most complex patients who require the greatest clinical input┻ We recommend that services should adopt a co┽ordinated┸ multidisciplinary approach aligned with current guidelines ゅば‒ひょ┸ but go further to recommend the need for specific professionals ゅincluding respiratory specialistsょ to be involved early and throughout the disease course to optimise adherence and ventilation┻ This will allow barriers to successful NIV use to be addressed prior to NIV initiation┻ The key benefits of this set┽up in optimising NIV use may be one explanation for why multidisciplinary care is associated with improved survival compared to non┽specialist services ゅぬに┸ ばど‒ばぬょ┻  Current guidelines make no reference to place of initiation┸ leading to practice variation ゅば‒ひょ┻ Outpatient or domiciliary initiation may promote acclimatisation┸ minimise patient anxiety and reduce delays in commencing NIV┻ In patients with chronic respiratory failure┸ outpatient ゅばねょ and domiciliary initiation ゅばのょ have been comparable to inpatient models in terms of adherence and ventilation and more cost┽effective┻ The American Academy for Sleep Medicine also suggest that inpatient initiation can be difficult to justify both medically and financially ゅばはょ┻ The Medical Research Council advise that complex interventions such as NIV work best if tailored and evaluated according to local circumstances rather than being completely standardised ゅはょ┻ Therefore┸ we recommend that outpatient ゅand perhaps homeょ initiation should be considered as an effective alternative to inpatient initiation┹ however┸ there should be means for more complex patients ゅe┻g┻ those with significant bulbar impairmentょ to receive greater attention┸ which could involve an inpatient stay and more intensive monitoring to optimise efficacy┻  We have highlighted the importance of the mask interface in NIV success and recommend that interface selection and fitting should be optimised to minimise leak and maximise comfort┻ This might involve offering a variety of interfaces and providing alternatives as necessary┻ Particular interfaces will have key benefits in certain scenarios┹ for instance┸ switching from an oronasal mask to a nasal mask with a chin strap to address obstructive events and the use of a mouthpiece in patients with adequate bulbar function to allow for daytime use and adjuvant cough augmentation┻ A recent review highlighted the broad range of airway clearance techniques available┸ which may be adapted according to individual patient requirements ゅばばょ┻ Secretion management via cough augmentation and various pharmacological methods should be optimised alongside NIV┻  It remains unclear which initial ventilator types┸ modes and settings are optimal but what is very clear is that setting adjustments are often required to achieve success┻ Ventilator choice may be restricted within certain health services┸ while the potentially damaging effects of using a spontaneous mode in patients with progressive respiratory muscle weakness must be considered ゅばはょ┻ Effective ventilation is likely to confer a survival advantage┸ so we recommend this should be a goal in the first few months post┽initiation whilst maintaining the balance between effective adherence┸ ventilation and comfort┻ To achieve this┸ and in contrast with published guidance┸ which suggests reviewing patients every two to three months ゅば‒ひょ┸ we recommend reviewing patients in the first few days and weeks to screen for and identify causes of poor efficacy and adjust NIV settings accordingly as adjustments appear to prolong survival ゅね┸ ねぱょ┻ Particular attention should be paid to patients at higher risk of difficulties┻ Clinicians should be vigilant in their assessment of the optimal interface and NIV settings over time┸ as they will likely need 
 
 
altering due to evolving bulbar dysfunction and gradual weakening of the respiratory muscles┻ The most appropriate tests to monitor ventilation remain unclear┻ A working group of ten European ventilation specialists recommended that more complex tests ゅe┻g┻ polysomnographyょ could have utility in titrating parameters┸ troubleshooting for problems and monitoring efficacy in more complex patients┸ but simple oximetry and ventilator┽recorded data may suffice in most cases ゅばぱょ┹ this would free up resources to focus on those with the most barriers to success┻ An RCT in patients using positive airway pressure for OSA found that use of a telemonitoring system that allowed clinicians to identify problems and make adjustments to the settings remotely significantly improved adherence versus those using standard care ゅばひょ┻ A にどなは systematic review recommended that further evidence is needed to demonstrate the value of telemonitoring in ALS ゅぱどょ┻  Currently there is a reluctance among some clinicians to offer NIV to patients with significant bulbar impairment ゅなどょ and current guidelines suggest that these patients should only receive a trial of NIV if they are likely to benefit from an improvement in sleep┽related symptoms ゅばょ┸ or should instead be offered tracheostomy┽assisted ventilation or palliative care ゅぱょ┻ Whilst patients with bulbar dysfunction face greater barriers to NIV success┸ the evidence suggests that they may gain both symptom and survival benefit that could be at least equal to that of non┽bulbar patients┻ This benefit depends on strategies to promote effective use┹ for example┸ attention to secretion management┸ interface optimisation┸ adequate initial acclimatisation and ongoing active management with vigilant monitoring and adjustments made as necessary┻ These complex patients derive the greatest benefit from a multidisciplinary approach ゅばなょ┻  Qualitative studies highlighted the need to identify and address the barriers to acceptance and adaptation of the patient and carer to life with NIV┻ However┸ there is a lack of evidence on interventions to support patients and carers┻ An ongoing RCT in patients with chronic obstructive pulmonary disease is evaluating the effects of counselling┸ relaxation┸ mindfulness┽based exercises and neuropsychological rehabilitation on NIV acceptance and adherence ゅぱなょ┻ One included study suggested that an educational programme can have a significant impact on adherence ゅにばょ┸ while another proposed offering psychological interventions where adherence is suboptimal ゅののょ┻  Strengths and limitations of this review This is a systematic examination of the evidence exploring the optimisation of NIV use in ALS┻ Due to the breadth of the review┸ reporting has been unable to examine each paper in depth┻ Studies identified were largely observational with a paucity of randomised controlled trials┻ Therefore┸ any conclusions drawn from this review must be interpreted in light of the limited high┽quality evidence available┻ Furthermore┸ any evidence must be considered in the context of individual patient and service needs┻ RCT evidence is likely to remain rare in this patient group due to ethical issues and clinical heterogeneity┻ Nonetheless┸ the review findings may be used to inform the development of guidelines for optimising the ALS patient care pathway and highlight areas that warrant further research ゅsee Table ぬょ┻   Conclusion There is a substantial body of evidence related to the optimal care of ALS patients on NIV┸ considering service┸ equipment┸ patient and carer factors┻ Factors optimising care for all patients include┺ effectively co┽ordinated multidisciplinary care┹ careful selection of interfaces┸ ventilator modes and settings appropriate for the individual patient┹ adequate secretion control┹ and 
 
 









Table ぬ┻ Evidence┽based recommendations 
Optimising factor Recommendations for practice Level of evidence Recommendations for research 
Multidisciplinary 
care 
The use of multidisciplinary clinics leads to greater NIV uptake┻  Eight studies┺  ┽ One prospective cohort ゅにばょ ┽ One retrospective before┽and┽after study ゅにぱょ ┽ Three cross┽sectional surveys ゅぬど┸ ぬな┸ ぬぬょ ┽ Two epidemiological studies ゅにひ┸ ぬにょ ┽ One audit ゅぬねょ  
To further characterise the impact of multidisciplinary care and the role of respiratory and speech therapy specialists in certain patients ゅe┻g┻ those with severe bulbar impairmentょ┻ 
 The involvement of respiratory specialists promotes good adherence┻   Three studies┺  ┽ One retrospective before┽and┽after study ゅにぱょ ┽ One cross┽sectional survey ゅぬどょ ┽ One audit ゅぬねょ   Effective co┽ordination between neurology and respiratory services leads to good usage┻   Two cross┽sectional surveys ゅぬど┸ ぬなょ 
Place of initiation Outpatient initiation of NIV is likely to be an effective┸ cost┽effective and acceptable alternative to inpatient initiation┻  Two studies┺  ┽ One RCT ゅなはょ ┽ One prospective before┽and┽after study ゅにはょ  
To strengthen the evidence for the comparative efficacy of domiciliary versus hospital inpatient and outpatient initiation┸ and explore patient preference┻   To assess the feasibility of managing the complexities of NIV initiation in a single outpatient session┻     
 Initiation at home may be an effective way for patients to acclimatise to the ventilator and interface┻   
One audit ゅぬねょ 




Interface Interface selection and fitting should be aimed at optimising adherence by maximising comfort to prevent interface┽related intolerance┻    Interface selection and fitting should also be aimed at optimising ventilation with a particular focus on minimising unintentional air leak┻    
Six studies┺ ┽ Two prospective cohorts ゅにに┸ ぬばょ ┽ One cross┽sectional survey ゅぬどょ ┽ One case report ゅねねょ ┽ Two qualitative studies ゅねは┸ ねばょ  Four studies┺ ┽ One randomised crossover trial ゅなぱょ ┽ One prospective cohort ゅぬぱょ ┽ Two retrospective cohorts ゅね┸ ぬひょ   
To explore the effect of different interfaces on patient adherence and the effectiveness of ventilation┻   To investigate the optimal interface for patients with bulbar and【or facial muscle weakness┻ 
 Particular interfaces should be available to trial in certain scenarios┸ for example┺ ┽ A mouthpiece for patients with adequate bulbar function to allow for convenient daytime ventilation and adjuvant cough augmentation┻    ┽ Switching from an oronasal mask to a nasal mask with a chin strap in the presence of obstructive events on NIV┻  
  Three studies┺  ┽ One RCT ゅぬょ ┽ One retrospective cohort ゅねどょ ┽ One case report ゅねぬょ  Two studies┺  ┽ One retrospective ゅぬひょ ┽ One case report ゅねにょ  
Machine type┸ 
mode and settings 
The choice of NIV machine┸ mode and settings should be adjusted according to the clinical scenario┹ if an individual patient demonstrates poor ventilation or adherence not related to the interface┸ consider changing┺  
 ┽ Machine settings ゅsee Table にょ   ┽ Machine mode     
      Six studies┺ ┽ Three retrospective studies ゅね┸ ぬひ┸ ねぱょ ┽ Three case reports ゅねの┸ のな┸ のにょ  Three studies┺ ┽ One randomised crossover trial ゅなばょ ┽ Two prospective cohorts ゅぬば┸ ぬぱょ  
To compare the efficacy of the different NIV machine types ゅpressure┸ volume┸ AVAPSょ and modes ゅspontaneous┸ timed┸ STょ┻   To explore the potential utility of continuous positive airway pressure ゅCPAPょ therapy in ALS patients with coexisting OSA┻   To further validate the accuracy of data provided by ventilator software ゅe┻g┻ tidal volumes┸ leakょ┻   
 
 





Cough┽assist machines for airway secretion clearance should be combined with NIV to maximise survival and quality of life benefits┻   
Five studies┺ ┽ Three retrospective cohorts ゅのは‒のぱょ   ┽ Two case reports ゅねぬ┸ ねねょ To compare the effectiveness and cost┽effectiveness of the various manual and mechanical airway clearance techniques that may be used in ALS┻  Ensure optimal oropharyngeal secretion control prior to and during NIV use to promote effective ventilation and good adherence┸ through the use of various pharmacological and non┽pharmacological methods┻   
Four studies┺  ┽ Two prospective cohorts ゅにな┸ にねょ ┽ One case report ゅのひょ ┽ One qualitative study ゅねはょ  
 
Monitoring Close monitoring of all patients in the first few days and weeks post┽initiation┻   Additional provision for those at higher risk of difficulties ゅe┻g┻ patients with severe bulbar impairmentょ┻   Monitoring to identify poor adherence and ineffective ventilation and the implementation of corrective measures that could extend survival┻   
Expert opinion┻   Expert opinion┻     Two retrospective studies ゅね┸ ねぱょ 
To explore a large scale┸ multidisciplinary initiation programme involving education┸ adaptive measures and monitoring┻   To explore the most clinically┽ and cost┽effective methods for monitoring the effectiveness of NIV┻  To explore the best methods for monitoring patients who are deteriorating on NIV┻   To further investigate the potential utility of telemonitoring of NIV in ALS and resolve the issues with current systems ゅe┻g┻ system specification┸ pre┽determined alerts and the delivery of a patient┽specific action planょ   
 Vigilant assessment of the optimal interface and NIV settings over time in the context of evolving bulbar dysfunction and gradual weakening of the respiratory muscles┻   
Two retrospective studies ゅに┸ はなょ 
Patient and carer 
perceptions 
Attention should be paid to psychosocial aspects of care for all patients initiating NIV and their caregivers┻  
Expert opinion┻  To explore the effects of different psychological interventions on NIV acceptance and adherence in ALS┻   
 
 
   Psychological interventions may be helpful where adherence is suboptimal┻   One qualitative study ゅののょ  
Bulbar impairment  Patients with significant bulbar dysfunction can still derive significant benefit from NIV if their needs are met┻       Measures that should be taken to promote effective NIV use in these patients include┺ ┽ Multidisciplinary care ┽ Effective secretion management  ┽ Optimisation of interface selection and fitting    ┽ Initial adaptation┸ which might involve more intensive inpatient initiation procedures than for those with better bulbar function                       ┽ Vigilant monitoring and troubleshooting                                                    ┽ Proactive management┸ including attention to the appropriate interface and machine settings over time 
なね studies┺ ┽ Two RCTs ゅぬ┸ なはょ ┽ Six prospective cohorts ゅにど┸ にな┸ にば┸ ぬば┸ ぬぱ┸ はのょ ┽ Five retrospective cohorts ゅの┸ ねな┸ のぱ┸ はね┸ はぱょ ┽ One cross┽sectional study ゅにひょ  Expert opinion┻   
To further examine the effect of these recommended measures on the efficacy of NIV in patients with significant bulbar dysfunction┻  
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ヶく  Cヴ;ｷｪ Pが DｷWヮヮW Pが M;Iｷﾐデ┞ヴW Sが MｷIｴｷW Sが N;┣;ヴWデｴ Iが PWデデｷIヴW┘ Mく DW┗Wﾉﾗヮｷﾐｪ ;ﾐS W┗;ﾉ┌;デｷﾐｪ 
IﾗﾏヮﾉW┝ ｷﾐデWヴ┗Wﾐデｷﾗﾐゲぎ TｴW ﾐW┘ MWSｷI;ﾉ RWゲW;ヴIｴ Cﾗ┌ﾐIｷﾉ ｪ┌ｷS;ﾐIWく Iﾐデ J N┌ヴゲ Sデ┌Sく 
ヲヰヱンきヵヰふヵぶぎヵΒΑにΓヲく  
Αく  N;デｷﾗﾐ;ﾉ Iﾐゲデｷデ┌デW aﾗヴ HW;ﾉデｴ ;ﾐS C;ヴW E┝IWﾉﾉWﾐIWく Mﾗデﾗヴ ﾐW┌ヴﾗﾐW SｷゲW;ゲWぎ ;ゲゲWゲゲﾏWﾐデ ;ﾐS 
ﾏ;ﾐ;ｪWﾏWﾐデ ふNICE ｪ┌ｷSWﾉｷﾐW NGヴヲぶ ぷIﾐデWヴﾐWデへく ヲヰヱヶく A┗;ｷﾉ;HﾉW aヴﾗﾏぎ 
ｴデデヮゲぎっっ┘┘┘くﾐｷIWくﾗヴｪく┌ﾆっｪ┌ｷS;ﾐIWっﾐｪヴヲっ 
Βく  AﾐSWヴゲWﾐ PMが AHヴ;ｴ;ﾏゲ Sが Bﾗヴ;ゲｷﾗ GDが SW C;ヴ┗;ﾉｴﾗ Mが Cｴｷﾗ Aが V;ﾐ D;ﾏﾏW Pが Wデ ;ﾉく EFNS 
ｪ┌ｷSWﾉｷﾐWゲ ﾗﾐ デｴW CﾉｷﾐｷI;ﾉ M;ﾐ;ｪWﾏWﾐデ ﾗa Aﾏ┞ﾗデヴﾗヮｴｷI L;デWヴ;ﾉ SIﾉWヴﾗゲｷゲ ふMALSぶ ど ヴW┗ｷゲWS 
ヴWヮﾗヴデ ﾗa ;ﾐ EFNS デ;ゲﾆ aﾗヴIWく E┌ヴ J NW┌ヴﾗﾉく ヲヰヱヲきヱΓふンぶぎンヶヰにΑヵく  
Γく  MｷﾉﾉWヴ RGが J;Iﾆゲﾗﾐ CEが K;ゲ;ヴゲﾆｷゲ EJが Eﾐｪﾉ;ﾐS JDが FﾗヴゲｴW┘ Dが Jﾗｴﾐゲデﾗﾐ Wが Wデ ;ﾉく Pヴ;IデｷIW 
P;ヴ;ﾏWデWヴ ┌ヮS;デWぎ TｴW I;ヴW ﾗa デｴW ヮ;デｷWﾐデ ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲぎ Dヴ┌ｪが 
ﾐ┌デヴｷデｷﾗﾐ;ﾉが ;ﾐS ヴWゲヮｷヴ;デﾗヴ┞ デｴWヴ;ヮｷWゲ ふ;ﾐ W┗ｷSWﾐIWどH;ゲWS ヴW┗ｷW┘ぶく NW┌ヴﾗﾉﾗｪ┞く 
ヲヰヰΓきΑンふヱヵぶぎヱヲヱΒにヲヶく  
ヱヰく  OげNWｷﾉﾉ CLが Wｷﾉﾉｷ;ﾏゲ TLが PWWﾉ ETが MIDWヴﾏﾗデデ CJが Sｴ;┘ PJが GｷHゲﾗﾐ GJが Wデ ;ﾉく Nﾗﾐどｷﾐ┗;ゲｷ┗W 
┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ﾏﾗデﾗヴ ﾐW┌ヴﾗﾐ SｷゲW;ゲWぎ Aﾐ ┌ヮS;デW ﾗa I┌ヴヴWﾐデ UK ヮヴ;IデｷIWく J NW┌ヴﾗﾉ NW┌ヴﾗゲ┌ヴｪ 
Pゲ┞Iｴｷ;デヴ┞く ヲヰヱヲきΒンふヴぶぎンΑヱにヶく  
ヱヱく  MﾗｴWヴ Dが LｷHWヴ;デｷ Aが TWデ┣ﾉ;aa Jが Aﾉデﾏ;ﾐ DGが Gヴﾗ┌ヮ TPく PヴWaWヴヴWS RWヮﾗヴデｷﾐｪ IデWﾏゲ aﾗヴ 
S┞ゲデWﾏ;デｷI RW┗ｷW┘ゲ ;ﾐS MWデ;どAﾐ;ﾉ┞ゲWゲぎ TｴW PRISMA Sデ;デWﾏWﾐデく PLOS MWS ぷIﾐデWヴﾐWデへく ヲヰヰΓ 
J┌ﾉ ヲヱきヶふΑぶぎWヱヰヰヰヰΓΑく A┗;ｷﾉ;HﾉW aヴﾗﾏぎ ｴデデヮゲぎっっSﾗｷくﾗヴｪっヱヰくヱンΑヱっﾃﾗ┌ヴﾐ;ﾉくヮﾏWSくヱヰヰヰヰΓΑ 
ヱヲく  CWﾐデヴW aﾗヴ RW┗ｷW┘ゲ ;ﾐS DｷゲゲWﾏｷﾐ;デｷﾗﾐ ぷIﾐデWヴﾐWデへく Yﾗヴﾆき ヲヰヰΒく A┗;ｷﾉ;HﾉW aヴﾗﾏぎ 
┘┘┘くIヴSく┞ﾗヴﾆく;Iく┌ﾆっIヴS┘WHっ 
ヱンく  Hｷｪｪｷﾐゲ Jが GヴWWﾐ Sく CﾗIｴヴ;ﾐW H;ﾐSHﾗﾗﾆ aﾗヴ S┞ゲデWﾏ;デｷI RW┗ｷW┘ゲ ﾗa IﾐデWヴ┗Wﾐデｷﾗﾐゲ VWヴゲｷﾗﾐ ヵくヱくヰ 
ぷ┌ヮS;デWS M;ヴIｴ ヲヰヱヱへ ぷIﾐデWヴﾐWデへく TｴW CﾗIｴヴ;ﾐW Cﾗﾉﾉ;Hﾗヴ;デｷﾗﾐく ヲヰヱヱく A┗;ｷﾉ;HﾉW aヴﾗﾏぎ 
┘┘┘くｴ;ﾐSHﾗﾗﾆくIﾗIｴヴ;ﾐWくﾗヴｪ 




ヱヵく  CヴｷデｷI;ﾉ Sﾆｷﾉﾉゲ Aヮヮヴ;ｷゲ;ﾉ Pヴﾗｪヴ;ﾏﾏW ふCASPぶ Q┌;ﾉｷデ;デｷ┗W RWゲW;ヴIｴ CｴWIﾆﾉｷゲデく A┗;ｷﾉ;HﾉW aヴﾗﾏぎ 
ｴデデヮゲぎっっI;ゲヮど┌ﾆくﾐWデっ┘ヮどIﾗﾐデWﾐデっ┌ヮﾉﾗ;SゲっヲヰヱΒっヰンっCASPどQ┌;ﾉｷデ;デｷ┗WどCｴWIﾆﾉｷゲデど
ヲヰヱΒぱaｷﾉﾉ;HﾉWぱaﾗヴﾏくヮSa 
ヱヶく  BWヴデWﾉﾉ; Eが B;ﾐaｷ Pが P;ﾐWヴﾗﾐｷ Mが Gヴｷﾉﾉｷ Sが Bｷ;ﾐIｴｷ Lが Vﾗﾉヮ;デﾗ Eが Wデ ;ﾉく E;ヴﾉ┞ ｷﾐｷデｷ;デｷﾗﾐ ﾗa ﾐｷｪｴデどデｷﾏW 
NIV ｷﾐ ;ﾐ ﾗ┌デヮ;デｷWﾐデ ゲWデデｷﾐｪぎ ; ヴ;ﾐSﾗﾏｷ┣WS ﾐﾗﾐどｷﾐaWヴｷﾗヴｷデ┞ ゲデ┌S┞ ｷﾐ ALS ヮ;デｷWﾐデゲく E┌ヴ J Pｴ┞ゲ 
RWｴ;Hｷﾉ MWSく ヲヰヱΑきヵンふヶぶぎΒΓヲにΓく  
ヱΑく  VヴｷﾃゲWﾐ Bが B┌┞ゲW Bが BWﾉｪW Cが V;ﾐヮWW Gが V;ﾐ D;ﾏﾏW Pが TWゲデWﾉﾏ;ﾐゲ Dく R;ﾐSﾗﾏｷ┣WS Iヴﾗゲゲどﾗ┗Wヴ 
デヴｷ;ﾉ ﾗa ┗Wﾐデｷﾉ;デﾗヴ ﾏﾗSWゲ S┌ヴｷﾐｪ ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ デｷデヴ;デｷﾗﾐ ｷﾐ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ 
ゲIﾉWヴﾗゲｷゲく RWゲヮｷヴﾗﾉﾗｪ┞く ヲヰヱΑきヲヲふヶぶぎヱヲヱヲにΒく  
ヱΒく  CヴWゲIｷﾏ;ﾐﾐﾗ Gが GヴWIﾗ Fが AヴヴｷゲｷI;デﾗ Sが Mﾗヴ;ﾐ; Nが M;ヴヴﾗﾐW Oく EaaWIデゲ ﾗa ヮﾗゲｷデｷ┗W WﾐS 
W┝ヮｷヴ;デﾗヴ┞ ヮヴWゲゲ┌ヴW ;Sﾏｷﾐｷゲデヴ;デｷﾗﾐ S┌ヴｷﾐｪ ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ヮ;デｷWﾐデゲ ;aaWIデWS H┞ 
;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲぎ A ヴ;ﾐSﾗﾏｷ┣WS Iヴﾗゲゲﾗ┗Wヴ ゲデ┌S┞く RWゲヮｷヴﾗﾉﾗｪ┞く ヲヰヱヶきヲヱふΑぶぎヱンヰΑに
ヱンく  
ヱΓく  LﾗヮWゲ SW AﾉﾏWｷS; JPが Pｷﾐデﾗ Aが Pｷﾐデﾗ Sが Oｴ;ﾐ; Bが SW C;ヴ┗;ﾉｴﾗ Mく EIﾗﾐﾗﾏｷI Iﾗゲデ ﾗa ｴﾗﾏWど
デWﾉWﾏﾗﾐｷデﾗヴｷﾐｪ I;ヴW aﾗヴ BｷPAPど;ゲゲｷゲデWS ALS ｷﾐSｷ┗ｷS┌;ﾉゲく Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ SIﾉWヴく 
ヲヰヱヲきヱンふヶぶぎヵンンにΑく  
ヲヰく  AHﾗ┌ゲゲﾗ┌;ﾐ LSが Kｴ;ﾐ SUが B;ﾐWヴﾃWW Mが Aヴヴﾗﾉｷｪ; ACが Mｷデゲ┌ﾏﾗデﾗ Hく OHﾃWIデｷ┗W ﾏW;ゲ┌ヴWゲ ﾗa デｴW 
WaaｷI;I┞ ﾗa ﾐﾗﾐｷﾐ┗;ゲｷ┗W ヮﾗゲｷデｷ┗WどヮヴWゲゲ┌ヴW ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲく M┌ゲIﾉW 
NWヴ┗Wく ヲヰヰヱきヲヴふンぶぎヴヰンにΓく  
ヲヱく  Lﾗ CﾗIﾗ Dが M;ヴIｴWゲW Sが PWゲIﾗ MCが L; BWﾉﾉ; Vが PｷIIﾗﾉｷ Fが Lﾗ CﾗIﾗ Aく Nﾗﾐｷﾐ┗;ゲｷ┗W ヮﾗゲｷデｷ┗Wど
ヮヴWゲゲ┌ヴW ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ALSぎ ヮヴWSｷIデﾗヴゲ ﾗa デﾗﾉWヴ;ﾐIW ;ﾐS ゲ┌ヴ┗ｷ┗;ﾉく NW┌ヴﾗﾉﾗｪ┞く ヲヰヰヶきヶΑふヵぶぎΑヶヱに
ヵく  
ヲヲく  M;ヴデｷﾐW┣ Dが S;ﾐIｴﾗ Jが SWヴ┗Wヴ; Eが M;ヴｷﾐ Jく TﾗﾉWヴ;ﾐIW ﾗa Vﾗﾉ┌ﾏW Cﾗﾐデヴﾗﾉ Nﾗﾐｷﾐ┗;ゲｷ┗W 
VWﾐデｷﾉ;デｷﾗﾐ ｷﾐ S┌HﾃWIデゲ Wｷデｴ Aﾏ┞ﾗデヴﾗヮｴｷI L;デWヴ;ﾉ SIﾉWヴﾗゲｷゲく RWゲヮｷヴ C;ヴWく ヲヰヱヵきヶヰふヱヲぶぎヱΑヶヵにΑヱく  
ヲンく  M┌ゲデa; Nが W;ﾉゲｴ Eが Bヴ┞;ﾐデ Vが L┞;ﾉﾉ RAが ASSｷﾐｪデﾗﾐどH;ﾉﾉ Jが GﾗﾉSゲデWｷﾐ LHが Wデ ;ﾉく TｴW WaaWIデ ﾗa 
ﾐﾗﾐｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ﾗﾐ ALS ヮ;デｷWﾐデゲ ;ﾐS デｴWｷヴ I;ヴWｪｷ┗Wヴゲく NW┌ヴﾗﾉﾗｪ┞く ヲヰヰヶきヶヶふΒぶぎヱヲヱヱにΑく  
ヲヴく  V;ﾐSWﾐHWヴｪｴW Nが V;ﾉﾉWデ AどEが PWデｷデﾃW;ﾐ Tが LW C;ﾏ Pが PW┞ゲゲﾗﾐ Sが G┌Wヴｷﾐ Cが Wデ ;ﾉく AHゲWﾐIW ﾗa 
;ｷヴ┘;┞ ゲWIヴWデｷﾗﾐ ;II┌ﾏ┌ﾉ;デｷﾗﾐ ヮヴWSｷIデゲ デﾗﾉWヴ;ﾐIW ﾗa ﾐﾗﾐｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ゲ┌HﾃWIデゲ ┘ｷデｴ 
;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲく RWゲヮｷヴ C;ヴWく ヲヰヱンきヵΒふΓぶぎヱヴヲヴにンヲく  
ヲヵく  SWヴ┗Wヴ; Eが S;ﾐIｴﾗ Jが B;ﾓ┌ﾉゲ Pが M;ヴｹﾐ Jく B┌ﾉH;ヴ ｷﾏヮ;ｷヴﾏWﾐデ ゲIﾗヴW ヮヴWSｷIデゲ ﾐﾗﾐｷﾐ┗;ゲｷ┗W ┗ﾗﾉ┌ﾏWど
I┞IﾉWS ┗Wﾐデｷﾉ;デｷﾗﾐ a;ｷﾉ┌ヴW S┌ヴｷﾐｪ ;ﾐ ;I┌デW ﾉﾗ┘Wヴ ヴWゲヮｷヴ;デﾗヴ┞ デヴ;Iデ ｷﾐaWIデｷﾗﾐ ｷﾐ ALSく J NW┌ヴﾗﾉ SIｷく 
ヲヰヱヵきンヵΒふヱにヲぶぎΒΑにΓヱく  
ヲヶく  SｴWWヴゲ Nが BWヴﾉﾗ┘ｷデ┣ DJが R;┌デWﾉ; Lが B;デIｴWﾉSWヴ Iが Hﾗヮﾆｷﾐゲﾗﾐ Kが Hﾗ┘;ヴS MEく Iﾏヮヴﾗ┗WS ゲ┌ヴ┗ｷ┗;ﾉ 
┘ｷデｴ ;ﾐ ;ﾏH┌ﾉ;デﾗヴ┞ ﾏﾗSWﾉ ﾗa ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾏヮﾉWﾏWﾐデ;デｷﾗﾐ ｷﾐ ﾏﾗデﾗヴ ﾐW┌ヴﾗﾐ 
SｷゲW;ゲWく Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ SIﾉWヴ Fヴﾗﾐデ DWｪWﾐWヴく ヲヰヱヴきヱヵふンにヴぶぎヱΒヰにヴく  
ヲΑく  Vﾗﾉ;ﾐデｷ Pが CｷHWﾉﾉ; Fが S;ヴ┗< Mが CｷIIﾗ D DWが Sヮ;ﾐW┗Wﾉﾉﾗ Aが Mﾗヴ; Gが Wデ ;ﾉく PヴWSｷIデﾗヴゲ ﾗa ﾐﾗﾐど
ｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ デﾗﾉWヴ;ﾐIW ｷﾐ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲく J NW┌ヴﾗﾉ SIｷく ヲヰヱヱきンヰンふヱに
ヲぶぎヱヱヴにΒく  
ヲΒく  K;ヴW┌ゲ SAが K;ｪWHWｷﾐ Sが R┌SﾐｷIﾆｷ SAく TｴW ｷﾏヮﾗヴデ;ﾐIW ﾗa ; ヴWゲヮｷヴ;デﾗヴ┞ デｴWヴ;ヮｷゲデ ｷﾐ デｴW ALS 
IﾉｷﾐｷIく Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ SIﾉWヴく ヲヰヰΒきΓふンぶぎヱΑンにヶく  
ヲΓく  Cｴｷﾗ Aが C;ﾉ┗ﾗ Aが Mﾗｪﾉｷ; Cが G;ﾏﾐ; Fが M;デデWｷ Aが M;┣┣ｷﾐｷ Lが Wデ ;ﾉく Nﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ 
;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲぎ ; ヱヰ ┞W;ヴ ヮﾗヮ┌ﾉ;デｷﾗﾐ H;ゲWS ゲデ┌S┞く J NW┌ヴﾗﾉ NW┌ヴﾗゲ┌ヴｪ 
Pゲ┞Iｴｷ;デヴ┞く ヲヰヱヲきΒンふヴぶぎンΑΑにΒヱく  
 
 
ンヰく  Rｷデゲﾏ; BRが BWヴｪWヴ MJが Cｴ;ヴﾉ;ﾐS DAが Kｴﾗ┌ヴ┞ MAが Pｴｷﾉﾉｷヮゲ JTが Q┌ﾗﾐ MJが Wデ ;ﾉく NIPPVぎ 
ヮヴW┗;ﾉWﾐIWが ;ヮヮヴﾗ;Iｴ ;ﾐS H;ヴヴｷWヴゲ デﾗ ┌ゲW ;デ C;ﾐ;Sｷ;ﾐ ALS IWﾐデヴWゲく C;ﾐ J NW┌ヴﾗﾉ SIｷく 
ヲヰヱヰきンΑふヱぶぎヵヴにヶヰく  
ンヱく  Vｷデ;II; Mが Vｷ;ﾐWﾉﾉﾗ Aく RWゲヮｷヴ;デﾗヴ┞ ﾗ┌デIﾗﾏWゲ ﾗa ヮ;デｷWﾐデゲ ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲぎ ;ﾐ 
Iデ;ﾉｷ;ﾐ ﾐ;デｷﾗﾐ┘ｷSW ゲ┌ヴ┗W┞く RWゲヮｷヴ C;ヴWく ヲヰヱンきヵΒふΓぶぎヱヴンンにヴヱく  
ンヲく  Cｴｷﾘ Aが Bﾗデデ;IIｴｷ Eが B┌aa; Cが M┌デ;ﾐｷ Rが Mﾗヴ; Gが PARALSく Pﾗゲｷデｷ┗W WaaWIデゲ ﾗa デWヴデｷ;ヴ┞ IWﾐデヴWゲ aﾗヴ 
;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲ ﾗﾐ ﾗ┌デIﾗﾏW ;ﾐS ┌ゲW ﾗa ｴﾗゲヮｷデ;ﾉ a;IｷﾉｷデｷWゲく J NW┌ヴﾗﾉ NW┌ヴﾗゲ┌ヴｪ 
Pゲ┞Iｴｷ;デヴ┞く ヲヰヰヶきΑΑふΒぶぎΓヴΒにヵヰく  
ンンく  Cｴｷﾗ Aが Sｷﾉ;ﾐｷ Vく Aﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲ I;ヴW ｷﾐ Iデ;ﾉ┞ぎ ; ﾐ;デｷﾗﾐ┘ｷSW ゲデ┌S┞ ｷﾐ ﾐW┌ヴﾗﾉﾗｪｷI;ﾉ 
IWﾐデWヴゲく J NW┌ヴﾗﾉ SIｷく ヲヰヰヱきヱΓヱふヱにヲぶぎヱヴヵにヵヰく  
ンヴく  Nｷ┝ﾗﾐ Iが PﾗヮﾆｷW┘ｷI┣ Fが B;ﾐWヴﾃWW Sが VｷﾐIWﾐデどSﾏｷデｴ Lが Oﾉｷ┗Wヴ Dく Uゲｷﾐｪ ; ﾃﾗｷﾐデ ;ヮヮヴﾗ;Iｴ デﾗ ﾐﾗﾐど
ｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ﾏﾗデﾗヴ ﾐW┌ヴﾗﾐW SｷゲW;ゲWく E┌ヴ J P;ﾉﾉｷ;デ C;ヴWく ヲヰヱヵきヲヲぎヱΒヲにヴく  
ンヵく  HWｷﾏ;ﾐどP;デデWヴゲﾗﾐ TDが C┌Sﾆﾗ┘ｷI┣ MEが DW C;ヴ┗;ﾉｴﾗ Mが GWﾐｪW Aが H;ヴSｷﾏ;ﾐ Oが J;Iﾆゲﾗﾐ CEが Wデ 
;ﾉく UﾐSWヴゲデ;ﾐSｷﾐｪ デｴW ┌ゲW ﾗa NIV ｷﾐ ALSぎ ヴWゲ┌ﾉデゲ ﾗa ;ﾐ ｷﾐデWヴﾐ;デｷﾗﾐ;ﾉ ALS ゲヮWIｷ;ﾉｷゲデ ゲ┌ヴ┗W┞く 
Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ SIﾉWヴ Fヴﾗﾐデ DWｪWﾐWヴく ヲヰヱΒきヱΓふヵにヶぶぎンンヱにヴヱく  
ンヶく  M;ヴデｷﾐ NHが L;┘ヴWﾐIW Vが M┌ヴヴ;┞ Jが J;ﾐゲゲWﾐ Aが Hｷｪｪｷﾐゲﾗﾐ Iが L┞;ﾉﾉ Rが Wデ ;ﾉく DWIｷゲｷﾗﾐ M;ﾆｷﾐｪ AHﾗ┌デ 
G;ゲデヴﾗゲデﾗﾏ┞ ;ﾐS Nﾗﾐｷﾐ┗;ゲｷ┗W VWﾐデｷﾉ;デｷﾗﾐ ｷﾐ Aﾏ┞ﾗデヴﾗヮｴｷI L;デWヴ;ﾉ SIﾉWヴﾗゲｷゲく Q┌;ﾉ HW;ﾉデｴ RWゲく 
ヲヰヱヶきヲヶふヱヰぶぎヱンヶヶにΒヱく  
ンΑく  VヴｷﾃゲWﾐ Bが B┌┞ゲW Bが BWﾉｪW Cが RﾗHHWヴWIｴデ Wが V;ﾐ D;ﾏﾏW Pが DWIヴ;ﾏWヴ Mが Wデ ;ﾉく Nﾗﾐｷﾐ┗;ゲｷ┗W 
┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾏヮヴﾗ┗Wゲ ゲﾉWWヮ ｷﾐ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲぎ A ヮヴﾗゲヮWIデｷ┗W ヮﾗﾉ┞ゲﾗﾏﾐﾗｪヴ;ヮｴｷI 
ゲデ┌S┞く J Cﾉｷﾐ SﾉWWヮ MWSく ヲヰヱヵきヱヱふヵぶぎヵヵΓにヶヶく  
ンΒく  VヴｷﾃゲWﾐ Bが TWゲデWﾉﾏ;ﾐゲ Dが BWﾉｪW Cが V;ﾐヮWW Gが V;ﾐ D;ﾏﾏW Pが B┌┞ゲW Bく P;デｷWﾐデど┗Wﾐデｷﾉ;デﾗヴ 
;ゲ┞ﾐIｴヴﾗﾐ┞が ﾉW;ﾆゲ ;ﾐS ゲﾉWWヮ ｷﾐ ヮ;デｷWﾐデゲ ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲく Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ 
SIﾉWヴ FヴﾗﾐデﾗデWﾏヮﾗヴ;ﾉ DWｪWﾐWヴく ヲヰヱヶきヱΑふヵにヶぶぎンヴンにヵヰく  
ンΓく  SIｴWﾉﾉｴ;ゲ Vが Gﾉ;デ┣ Cが BWWIﾆWﾐ Iが OﾆWｪ┘ﾗ Aが HWｷSHヴWSWヴ Aが Yﾗ┌ﾐｪ Pが Wデ ;ﾉく UヮヮWヴ ;ｷヴ┘;┞ 
ﾗHゲデヴ┌Iデｷﾗﾐ ｷﾐS┌IWS H┞ ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ┌ゲｷﾐｪ ;ﾐ ﾗヴﾗﾐ;ゲ;ﾉ ｷﾐデWヴa;IWく SﾉWWヮ BヴW;デｴく 
ヲヰヱΒきヲヲふンぶぎΑΒヱにΒく  
ヴヰく  BWS;ヴS MどEが MIKｷﾏ DAく D;┞デｷﾏW Mﾗ┌デｴヮｷWIW aﾗヴ Cﾗﾐデｷﾐ┌ﾗ┌ゲ Nﾗﾐｷﾐ┗;ゲｷ┗W VWﾐデｷﾉ;デｷﾗﾐ ｷﾐ 
IﾐSｷ┗ｷS┌;ﾉゲ Wｷデｴ Aﾏ┞ﾗデヴﾗヮｴｷI L;デWヴ;ﾉ SIﾉWヴﾗゲｷゲく RWゲヮｷヴ C;ヴWく ヲヰヱヶきヶヱふヱヰぶぎヱンヴヱにΒく  
ヴヱく  BﾗWﾐデWヴデ Mが BヴWﾐゲIｴWｷSデ Iが Gﾉ;デ┣ Cが Yﾗ┌ﾐｪ Pく EaaWIデゲ ﾗa ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ﾗﾐ ﾗHﾃWIデｷ┗W 
ゲﾉWWヮ ;ﾐS ﾐﾗIデ┌ヴﾐ;ﾉ ヴWゲヮｷヴ;デｷﾗﾐ ｷﾐ ヮ;デｷWﾐデゲ ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲく J NW┌ヴﾗﾉく 
ヲヰヱヵきヲヶヲふΓぶぎヲヰΑンにΒヲく  
ヴヲく  VヴｷﾃゲWﾐ Bが B┌┞ゲW Bが BWﾉｪW Cが TWゲデWﾉﾏ;ﾐゲ Dく UヮヮWヴ ;ｷヴ┘;┞ ﾗHゲデヴ┌Iデｷﾗﾐ S┌ヴｷﾐｪ ﾐﾗﾐｷﾐ┗;ゲｷ┗W 
┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐS┌IWS H┞ デｴW ┌ゲW ﾗa ;ﾐ ﾗヴﾗﾐ;ゲ;ﾉ ﾏ;ゲﾆく J Cﾉｷﾐ SﾉWWヮ MWSく ヲヰヱヴきヱヰふΓぶぎヱヰンンにヵく  
ヴンく  Aｪヴ;aｷﾗデｷゲ Mが P;ヮ;ﾐｷﾆﾗﾉ;ﾗ┌ Gが Hﾗゲヮｷデ;ﾉ Gが Tヴ┞aﾗﾐ Sが Hﾗゲヮｷデ;ﾉ Gが OHゲデヴ┌Iデｷ┗W Cが Wデ ;ﾉく 
Nﾗﾐｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ┗ｷ; ﾏﾗ┌デｴヮｷWIW ｷﾐ ; ヮ;デｷWﾐデ ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲぎ A 
ﾏWデｴﾗS デﾗ ;┗ﾗｷS デヴ;IｴWﾗゲデﾗﾏ┞ ;ﾐS ｷﾏヮヴﾗ┗W Iﾗ┌ｪｴ WaaｷI;I┞く PﾐW┌ﾏﾗﾐく ヲヰヱΑきンヰふヲぶぎンヱにヵく  
ヴヴく  BWﾉIｴｷﾗヴ Iが GﾗﾐI;ﾉ┗Wゲ MRが WｷﾐIﾆ JCく Cﾗﾐデｷﾐ┌ﾗ┌ゲ ﾐﾗﾐｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ SWﾉｷ┗WヴWS H┞ ; ﾐﾗ┗Wﾉ 
デﾗデ;ﾉ a;IW ﾏ;ゲﾆぎ ; I;ゲW ゲWヴｷWゲ ヴWヮﾗヴデく RWゲヮｷヴ C;ヴWく ヲヰヱヲきヵΑふンぶぎヴヴΓにヵンく  
ヴヵく  Dｷ;┣どAH;S Mが Bヴﾗ┘ﾐ JEく UゲW ﾗa ┗ﾗﾉ┌ﾏWどデ;ヴｪWデWS ﾐﾗﾐどｷﾐ┗;ゲｷ┗W HｷﾉW┗Wﾉ ヮﾗゲｷデｷ┗W ;ｷヴ┘;┞ ヮヴWゲゲ┌ヴW 
┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ; ヮ;デｷWﾐデ ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲがく J Bヴ;ゲ PﾐW┌ﾏﾗﾉく ヲヰヱヴきヴヰふヴぶぎヴヴンにΑく  
ヴヶく  B;┝デWヴ SKが B;ｷヴS WOが Tｴﾗﾏヮゲﾗﾐ Sが Bｷ;ﾐIｴｷ SMが W;ﾉデWヴゲ SJが LWW Eが Wデ ;ﾉく TｴW ｷﾐｷデｷ;デｷﾗﾐ ﾗa ﾐﾗﾐど
 
 
ｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ aﾗヴ ヮ;デｷWﾐデゲ ┘ｷデｴ ﾏﾗデﾗヴ ﾐW┌ヴﾗﾐ SｷゲW;ゲWぎ ヮ;デｷWﾐデ ;ﾐS I;ヴWヴ ヮWヴIWヮデｷﾗﾐゲ ﾗa 
ﾗHゲデ;IﾉWゲ ;ﾐS ﾗ┌デIﾗﾏWゲく Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ SIﾉWヴ FヴﾗﾐデﾗデWﾏヮﾗヴ;ﾉ DWｪWﾐWヴく ヲヰヱンきヱヴふヲぶぎヱヰヵに
ヱヰく  
ヴΑく  S┌ﾐSﾉｷﾐｪ IどMが Eﾆﾏ;ﾐ SどLが WWｷﾐHWヴｪ Jが KﾉWaHWIﾆ Bく P;デｷWﾐデゲげ ┘ｷデｴ ALS ;ﾐS I;ヴWｪｷ┗Wヴゲげ 
W┝ヮWヴｷWﾐIWゲ ﾗa ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ｴﾗﾏW ┗Wﾐデｷﾉ;デｷﾗﾐく AS┗ Pｴ┞ゲｷﾗデｴWヴく ヲヰヰΓきヱヱふンぶぎヱヱヴにヲヰく  
ヴΒく  GWﾗヴｪWゲ Mが Aデデ;ﾉｷ Vが Gﾗﾉﾏ;ヴS JLが MﾗヴYﾉﾗデどP;ﾐ┣ｷﾐｷ Cが CヴW┗ｷWヴどB┌Iｴﾏ;ﾐ Lが CﾗﾉﾉWデ JMが Wデ ;ﾉく 
RWS┌IWS ゲ┌ヴ┗ｷ┗;ﾉ ｷﾐ ヮ;デｷWﾐデゲ ┘ｷデｴ ALS ┘ｷデｴ ┌ヮヮWヴ ;ｷヴ┘;┞ ﾗHゲデヴ┌Iデｷ┗W W┗Wﾐデゲ ﾗﾐ ﾐﾗﾐどｷﾐ┗;ゲｷ┗W 
┗Wﾐデｷﾉ;デｷﾗﾐく J NW┌ヴﾗﾉ NW┌ヴﾗゲ┌ヴｪ Pゲ┞Iｴｷ;デヴ┞く ヲヰヱヶきΒΑふヱヰぶぎヱヰヴヵにヵヰく  
ヴΓく  NｷIｴﾗﾉゲﾗﾐ TTが Sﾏｷデｴ SBが SｷSSｷケ┌W Tが S┌aｷデ Rが Aﾃヴﾗ┌SどDヴｷゲゲ Sが CﾗﾉWﾏ;ﾐ JMが Wデ ;ﾉく RWゲヮｷヴ;デﾗヴ┞ 
P;デデWヴﾐ ;ﾐS TｷS;ﾉ Vﾗﾉ┌ﾏWゲ DｷaaWヴ aﾗヴ PヴWゲゲ┌ヴW S┌ヮヮﾗヴデ ;ﾐS Vﾗﾉ┌ﾏWど;ゲゲ┌ヴWS PヴWゲゲ┌ヴW S┌ヮヮﾗヴデ 
ｷﾐ Aﾏ┞ﾗデヴﾗヮｴｷI L;デWヴ;ﾉ SIﾉWヴﾗゲｷゲく Aﾐﾐ Aﾏ Tｴﾗヴ;I SﾗIく ヲヰヱΑきヱヴふΑぶぎヱヱンΓにヴヶく  
ヵヰく  VWﾉSｴ┌ｷゲ SKBが Dﾗaa MHJが SデWｪWﾐｪ; Bが NｷW┌┘Wﾐｴ┌ｷゲ JAが Wｷﾃﾆゲデヴ; PJく Oヴ;ﾉ ;ヮヮﾉｷ;ﾐIW デﾗ ;ゲゲｷゲデ 
ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ; ヮ;デｷWﾐデ ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲく SﾉWWヮ BヴW;デｴく 
ヲヰヱヵきヱΓふヱぶぎヶヱにンく  
ヵヱく  P;ヴﾆ Dく AヮヮﾉｷI;デｷﾗﾐ ﾗa SｷaaWヴWﾐデ ┗Wﾐデｷﾉ;デﾗヴ ﾏﾗSWゲ ｷﾐ ヮ;デｷWﾐデゲ ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ 
ゲIﾉWヴﾗゲｷゲ ;IIﾗヴSｷﾐｪ デﾗ IWヴデ;ｷﾐ IﾉｷﾐｷI;ﾉ ゲｷデ┌;デｷﾗﾐゲぎ A C;ゲW RWヮﾗヴデく MWSｷIｷﾐW ふB;ﾉデｷﾏﾗヴWぶく 
ヲヰヱΑきΓヶふンヴぶぎWΑΒΓΓく  
ヵヲく  H;ﾐﾐ;ﾐ LMが R;┌デWﾉ; Lが Wｷﾉゲﾗﾐ DLが BWヴﾉﾗ┘ｷデ┣ DJが Hﾗ┘;ヴS MEく AﾉデWヴｷﾐｪ ┗Wﾐデｷﾉ;デﾗヴ ｷﾐゲヮｷヴ;デﾗヴ┞ 
デｷﾏW I;ﾐ ヴWS┌IW ;┌デﾗI┞Iﾉｷﾐｪ S┌ヴｷﾐｪ ゲﾉWWヮく SﾉWWヮ MWSく ヲヰヱヵきヱヶふヱヰぶぎヱンヰヱにンく  
ヵンく  Y;ﾏ;S; Sが Nｷゲｴｷﾏｷ┞; Jが K┌ヴﾗﾆ;┘; Kが Y┌;ゲ; Tが M;ゲ;ﾆ; Aく BｷﾉW┗Wﾉ ﾐ;ゲ;ﾉ ヮﾗゲｷデｷ┗W ;ｷヴ┘;┞ ヮヴWゲゲ┌ヴW 
;ﾐS H;ﾉﾉﾗﾗﾐｷﾐｪ ﾗa デｴW ゲデﾗﾏ;Iｴく CｴWゲデく ヲヰヰヱきヱヱΓふヶぶぎヱΓヶヵにヶく  
ヵヴく  AﾐSﾗ Hが Cｴ;ﾆヴ;H;ヴデｷ Bが Aﾐｪ┌ゲ RMが Cﾗ┌ゲｷﾐゲ Rが Tｴﾗヴﾐデﾗﾐ EWが Yﾗ┌ﾐｪ CAく E┝ヮWヴｷWﾐIW ﾗa ﾉﾗﾐｪど
デWヴﾏ ┌ゲW ﾗa ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ﾏﾗデﾗヴ ﾐW┌ヴﾗﾐ SｷゲW;ゲWぎ ;ﾐ ｷﾐデWヴヮヴWデ;デｷ┗W 
ヮｴWﾐﾗﾏWﾐﾗﾉﾗｪｷI;ﾉ ;ﾐ;ﾉ┞ゲｷゲく BMJ S┌ヮヮﾗヴデ P;ﾉﾉｷ;デ C;ヴWく ヲヰヱヴきヴふヱぶぎヵヰにヶく  
ヵヵく  AﾐSﾗ Hが Wｷﾉﾉｷ;ﾏゲ Cが Aﾐｪ┌ゲ RMが Tｴﾗヴﾐデﾗﾐ EWが Cｴ;ﾆヴ;H;ヴデｷ Bが Cﾗ┌ゲｷﾐゲ Rが Wデ ;ﾉく Wｴ┞ Sﾗﾐげデ デｴW┞ 
;IIWヮデ ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐいぎ ｷﾐゲｷｪｴデ ｷﾐデﾗ デｴW ｷﾐデWヴヮWヴゲﾗﾐ;ﾉ ヮWヴゲヮWIデｷ┗Wゲ ﾗa ヮ;デｷWﾐデゲ ┘ｷデｴ 
ﾏﾗデﾗヴ ﾐW┌ヴﾗﾐW SｷゲW;ゲWく Bヴ J HW;ﾉデｴ Pゲ┞Iｴﾗﾉく ヲヰヱヵきヲヰふヲぶぎンヴヱにヵΓく  
ヵヶく  B;Iｴ JRく Aﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲぎ ヮヴﾗﾉﾗﾐｪ;デｷﾗﾐ ﾗa ﾉｷaW H┞ ﾐﾗﾐｷﾐ┗;ゲｷ┗W ヴWゲヮｷヴ;デﾗヴ┞ ;ｷSゲく 
CｴWゲデく ヲヰヰヲきヱヲヲふヱぶぎΓヲにΒく  
ヵΑく  B;Iｴ JRが Bｷ;ﾐIｴｷ Cが A┌aｷWヴﾗ Eく O┝ｷﾏWデヴ┞ ;ﾐS ｷﾐSｷI;デｷﾗﾐゲ aﾗヴ デヴ;IｴWﾗデﾗﾏ┞ aﾗヴ ;ﾏ┞ﾗデヴﾗヮｴｷI 
ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲく CｴWゲデく ヲヰヰヴきヱヲヶふヵぶぎヱヵヰヲにΑく  
ヵΒく  Kｴ;ﾏ;ﾐﾆ;ヴ Nが Cﾗ;ﾐ Gが WW;┗Wヴ Bが MｷデIｴWﾉﾉ CSく AゲゲﾗIｷ;デｷ┗W IﾐIヴW;ゲWゲ ｷﾐ Aﾏ┞ﾗデヴﾗヮｴｷI L;デWヴ;ﾉ 
SIﾉWヴﾗゲｷゲ S┌ヴ┗ｷ┗;ﾉ D┌ヴ;デｷﾗﾐ Wｷデｴ Nﾗﾐどｷﾐ┗;ゲｷ┗W VWﾐデｷﾉ;デｷﾗﾐ Iﾐｷデｷ;デｷﾗﾐ ;ﾐS Uゲ;ｪW PヴﾗデﾗIﾗﾉゲく 
Fヴﾗﾐデ NW┌ヴﾗﾉく ヲヰヱΒきΓぎヵΑΒく  
ヵΓく  CﾗﾗヮWヴどKﾐﾗIﾆ Jが AｴﾏWS┣;ｷ SHが Sｴ;┘ Pく TｴW ┌ゲW ﾗa ゲ┌HI┌デ;ﾐWﾗ┌ゲ ｪﾉ┞Iﾗヮ┞ヴヴﾗﾉ;デW ｷﾐ デｴW 
ﾏ;ﾐ;ｪWﾏWﾐデ ﾗa ゲｷ;ﾉﾗヴヴｴﾗW; ;ﾐS a;Iｷﾉｷデ;デｷﾐｪ デｴW ┌ゲW ﾗa ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ 
;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲく Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ SIﾉWヴく ヲヰヱヱきヱヲふヶぶぎヴヶヴにヵく  
ヶヰく  T;ﾏヮﾉｷﾐ Jが B;ﾆWヴ Fが D;┗ｷWゲ Rが B;ﾃﾗ Eが BﾗﾉｪWヴ Kが SｴWWヴゲ Nが Wデ ;ﾉく E┝ヮﾉﾗヴｷﾐｪ デｴW aW;ゲｷHｷﾉｷデ┞ ﾗa ; 
ﾏ┌ゲｷIど;ゲゲｷゲデWS ヴWﾉ;┝;デｷﾗﾐ ｷﾐデWヴ┗Wﾐデｷﾗﾐ デﾗ ;ゲゲｷゲデ ┘ｷデｴ デｴW ｷﾐｷデｷ;デｷﾗﾐ ﾗa ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ 
ｷﾐ ヮWﾗヮﾉW ┘ｷデｴ Mﾗデﾗヴ NW┌ヴﾗﾐ DｷゲW;ゲWく M┌ゲｷI MWSく ヲヰヱΑきΓぎΒヶにΓΑく  
ヶヱく  Gヴ┌ｷゲ KLが Bヴﾗ┘ﾐ DLが Lｷゲ;HWデｴ LDが ZWH;ヴ;ｴ VAが CｴWヴ┗ｷﾐ RDが FWﾉSﾏ;ﾐ ELく Lﾗﾐｪｷデ┌Sｷﾐ;ﾉ 
;ゲゲWゲゲﾏWﾐデ ﾗa ﾐﾗﾐｷﾐ┗;ゲｷ┗W ヮﾗゲｷデｷ┗W ヮヴWゲゲ┌ヴW ┗Wﾐデｷﾉ;デｷﾗﾐ ;Sﾃ┌ゲデﾏWﾐデゲ ｷﾐ ALS ヮ;デｷWﾐデゲく J NW┌ヴﾗﾉ 
SIｷく ヲヰヰヶきヲヴΑふヱぶぎヵΓにヶンく  
 
 
ヶヲく  Oﾉｷ┗Wヴ Dが B;ﾐWヴﾃWW Sが VｷﾐIWﾐデどSﾏｷデｴ Lが KｷﾐSヴWS Jが M;ヴデｷﾐ Kく TｴW ┌ゲW ﾗa ; ｴ;ﾐS ｴWﾉS ┗Wﾐデｷﾉ;デﾗヴ デﾗ 
ゲ┌ヮヮﾉWﾏWﾐデ NIV aﾗヴ ヮ;デｷWﾐデゲ ┘ｷデｴ ALSっMND ┘ｷデｴ ヴWゲヮｷヴ;デﾗヴ┞ ｷﾐゲ┌aaｷIｷWﾐI┞く Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ 
SIﾉWヴ FヴﾗﾐデﾗデWﾏヮﾗヴ;ﾉ DWｪWﾐWヴく ヲヰヱΒきヱΓふンにヴぶぎンヱンにヴく  
ヶンく  B┌デ┣ Mが Wﾗﾉﾉｷﾐゲﾆ┞ KHが WｷWSWﾏ┌デｴどC;デヴｷﾐWゲI┌ Uが SヮWヴaWﾉS Aが WｷﾐデWヴ Sが MWｴヴﾆWﾐゲ HHが Wデ ;ﾉく 
Lﾗﾐｪｷデ┌Sｷﾐ;ﾉ WaaWIデゲ ﾗa ﾐﾗﾐｷﾐ┗;ゲｷ┗W ヮﾗゲｷデｷ┗WどヮヴWゲゲ┌ヴW ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ヮ;デｷWﾐデゲ ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI 
ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲく Aﾏ J Pｴ┞ゲ MWS RWｴ;Hｷﾉく ヲヰヰンきΒヲふΒぶぎヵΓΑにヶヰヴく  
ヶヴく  F;ヴヴWヴﾗ Eが Pヴ;デゲ Eが Pﾗ┗WS;ﾐﾗ Mが M;ヴデｷﾐW┣どM;デﾗゲ JAが M;ﾐヴWゲ; Fが EゲI;ヴヴ;Hｷﾉﾉ Jく S┌ヴ┗ｷ┗;ﾉ ｷﾐ 
;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲ ┘ｷデｴ ｴﾗﾏW ﾏWIｴ;ﾐｷI;ﾉ ┗Wﾐデｷﾉ;デｷﾗﾐぎ デｴW ｷﾏヮ;Iデ ﾗa ゲ┞ゲデWﾏ;デｷI 
ヴWゲヮｷヴ;デﾗヴ┞ ;ゲゲWゲゲﾏWﾐデ ;ﾐS H┌ﾉH;ヴ ｷﾐ┗ﾗﾉ┗WﾏWﾐデく CｴWゲデく ヲヰヰヵきヱヲΑふヶぶぎヲヱンヲにΒく  
ヶヵく  Bﾗ┌ヴﾆW SCが B┌ﾉﾉﾗIﾆ REが Wｷﾉﾉｷ;ﾏゲ TLが Sｴ;┘ PJが GｷHゲﾗﾐ GJく Nﾗﾐｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ALSぎ 
ｷﾐSｷI;デｷﾗﾐゲ ;ﾐS WaaWIデ ﾗﾐ ケ┌;ﾉｷデ┞ ﾗa ﾉｷaWく NW┌ヴﾗﾉﾗｪ┞く ヲヰヰンきヶヱふヲぶぎヱΑヱにΑく  
ヶヶく  J;Iﾆゲﾗﾐ CEが Lﾗ┗ｷデデ Sが Gﾗ┘S; Nが AﾐSWヴゲﾗﾐ Fが MｷﾉﾉWヴ RGく F;Iデﾗヴゲ IﾗヴヴWﾉ;デWS ┘ｷデｴ NPPV ┌ゲW ｷﾐ 
ALSく Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ SIﾉWヴく ヲヰヰヶきΑふヲぶぎΒヰにヵく  
ヶΑく  DW Vｷデﾗ ELが S┌;ヴW┣ AAが MﾗﾐデWｷヴﾗ SGく TｴW ┌ゲW ﾗa a┌ﾉﾉどゲWデデｷﾐｪ ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ デｴW 
ｴﾗﾏW I;ヴW ﾗa ヮWﾗヮﾉW ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲどﾏﾗデﾗヴ ﾐW┌ヴﾗﾐ SｷゲW;ゲW ┘ｷデｴ WﾐSどゲデ;ｪW 
ヴWゲヮｷヴ;デﾗヴ┞ ﾏ┌ゲIﾉW a;ｷﾉ┌ヴWぎ ; I;ゲW ゲWヴｷWゲく J MWS C;ゲW RWヮく ヲヰヱヲきヶぎヴヲく  
ヶΒく  BWヴﾉﾗ┘ｷデ┣ DJが Hﾗ┘;ヴS MEが Jヴ JFFが Hﾗﾗヴﾐ S V;ﾐSWヴが Dﾗﾐﾗｪｴ┌W FJOが WWゲデﾉ;ﾆW Jが Wデ ;ﾉく ISWﾐデｷa┞ｷﾐｪ 
┘ｴﾗ ┘ｷﾉﾉ HWﾐWaｷデ aヴﾗﾏ ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲ っ ﾏﾗデﾗヴ 
ﾐW┌ヴﾗﾐW SｷゲW;ゲW ｷﾐ ; IﾉｷﾐｷI;ﾉ Iﾗｴﾗヴデく J NW┌ヴﾗﾉ NW┌ヴﾗゲ┌ヴｪ Pゲ┞Iｴｷ;デヴ┞く ヲヰヱヵきΒΑぎヱにΑく  
ヶΓく  LWﾏﾗｷｪﾐ;ﾐ Jが Eﾉﾉゲ Cく Aﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲ ;ﾐS ;ゲゲｷゲデWS ┗Wﾐデｷﾉ;デｷﾗﾐぎ ｴﾗ┘ ヮ;デｷWﾐデゲ 
SWIｷSWく P;ﾉﾉｷ;デ S┌ヮヮﾗヴデ C;ヴWく ヲヰヱヰきΒふヲぶぎヲヰΑにヱンく  
Αヰく  AヴｷSWｪHW Tが K;ﾐSﾉWヴ Rが W;ﾉデWヴゲ SJが W;ﾉゲｴ Tが Sｴ;┘ PJが MIDWヴﾏﾗデデ CJく TｴW ﾐ;デ┌ヴ;ﾉ ｴｷゲデﾗヴ┞ ﾗa 
ﾏﾗデﾗヴ ﾐW┌ヴﾗﾐ SｷゲW;ゲWぎ AゲゲWゲゲｷﾐｪ デｴW ｷﾏヮ;Iデ ﾗa ゲヮWIｷ;ﾉｷゲデ I;ヴWく Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ SIﾉWヴ Fヴﾗﾐデ 
DWｪWﾐWヴく ヲヰヱンきヱヴふヱぶぎヱンにΓく  
Αヱく  Tヴ;┞ﾐﾗヴ BJが AﾉW┝;ﾐSWヴ Mが Cﾗヴヴ Bが Fヴﾗゲデ Eが H;ヴSｷﾏ;ﾐ Oく EaaWIデ ﾗa ; ﾏ┌ﾉデｷSｷゲIｷヮﾉｷﾐ;ヴ┞ 
;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲ ふALSぶ IﾉｷﾐｷI ﾗﾐ ALS ゲ┌ヴ┗ｷ┗;ﾉぎ ; ヮﾗヮ┌ﾉ;デｷﾗﾐ H;ゲWS ゲデ┌S┞が ヱΓΓヶに
ヲヰヰヰく J NW┌ヴﾗﾉ NW┌ヴﾗゲ┌ヴｪ Pゲ┞Iｴｷ;デヴ┞く ヲヰヰンきΑヴふΓぶぎヱヲヵΒにヶヱく  
Αヲく  RﾗﾗﾐW┞ Jが B┞ヴﾐW Sが HW┗Wヴｷﾐ Mが TﾗHｷﾐ Kが DｷIﾆ Aが Dﾗﾐ;ｪｴ┞ Cが Wデ ;ﾉく A ﾏ┌ﾉデｷSｷゲIｷヮﾉｷﾐ;ヴ┞ IﾉｷﾐｷI 
;ヮヮヴﾗ;Iｴ ｷﾏヮヴﾗ┗Wゲ ゲ┌ヴ┗ｷ┗;ﾉ ｷﾐ ALSぎ ; Iﾗﾏヮ;ヴ;デｷ┗W ゲデ┌S┞ ﾗa ALS ｷﾐ IヴWﾉ;ﾐS ;ﾐS NﾗヴデｴWヴﾐ 
IヴWﾉ;ﾐSく J NW┌ヴﾗﾉ NW┌ヴﾗゲ┌ヴｪ わ;ﾏヮき;ﾏヮき Pゲ┞Iｴｷ;デヴ┞く ヲヰヱヵきΒヶふヵぶぎヴΓヶにヵヰヱく  
Αンく  RﾗSヴｹｪ┌W┣ SW Rｷ┗Wヴ; FJが OヴWﾃ; G┌W┗;ヴ; Cが S;ﾐ┣ G;ﾉﾉWｪﾗ Iが S;ﾐ JﾗゲY V;ﾉｷWﾐデW Bが S;ﾐデｷ;ｪﾗ 
RWI┌WヴS; Aが GﾙﾏW┣ MWﾐSｷWデ; MAが Wデ ;ﾉく O┌デIﾗﾏW ﾗa ヮ;デｷWﾐデゲ ┘ｷデｴ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ 
ゲIﾉWヴﾗゲｷゲ ;デデWﾐSｷﾐｪ ｷﾐ ; ﾏ┌ﾉデｷSｷゲIｷヮﾉｷﾐ;ヴ┞ I;ヴW ┌ﾐｷデく NW┌ヴﾗﾉﾗｪｹ;く ヲヰヱヱきヲヶふΒぶぎヴヵヵにヶヰく  
Αヴく  Cｴ;デ┘ｷﾐ Mが NｷIﾆﾗﾉ AHが MﾗヴヴWﾉﾉ MJが PﾗﾉﾆW┞ MIが SｷﾏﾗﾐSゲ AKく R;ﾐSﾗﾏｷゲWS デヴｷ;ﾉ ﾗa ｷﾐヮ;デｷWﾐデ 
┗Wヴゲ┌ゲ ﾗ┌デヮ;デｷWﾐデ ｷﾐｷデｷ;デｷﾗﾐ ﾗa ｴﾗﾏW ﾏWIｴ;ﾐｷI;ﾉ ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ヮ;デｷWﾐデゲ ┘ｷデｴ ﾐﾗIデ┌ヴﾐ;ﾉ 
ｴ┞ヮﾗ┗Wﾐデｷﾉ;デｷﾗﾐく RWゲヮｷヴ MWSく ヲヰヰΒきヱヰヲふヱヱぶぎヱヵヲΒにンヵく  
Αヵく  H;┣WﾐHWヴｪ Aが KWヴゲデﾃWﾐゲ HAMが Pヴｷﾐゲ SCLが VWヴﾏW┌ﾉWﾐ KMが Wｷﾃﾆゲデヴ; PJく Iﾐｷデｷ;デｷﾗﾐ ﾗa ｴﾗﾏW 
ﾏWIｴ;ﾐｷI;ﾉ ┗Wﾐデｷﾉ;デｷﾗﾐ ;デ ｴﾗﾏWぎ A ヴ;ﾐSﾗﾏｷゲWS IﾗﾐデヴﾗﾉﾉWS デヴｷ;ﾉ ﾗa WaaｷI;I┞が aW;ゲｷHｷﾉｷデ┞ ;ﾐS 
Iﾗゲデゲく RWゲヮｷヴ MWSく ヲヰヱヴきヱヰΒふΓぶぎヱンΒΑにΓヵく  
Αヶく  BWヴヴ┞ RBが CｴWSｷ;ﾆ Aが Bヴﾗ┘ﾐ LKが FｷﾐSWヴ Jが Gﾗ┣;ﾉ Dが IHWヴ Cが Wデ ;ﾉく BWゲデ IﾉｷﾐｷI;ﾉ ヮヴ;IデｷIWゲ aﾗヴ デｴW 
ゲﾉWWヮ IWﾐデWヴ ;Sﾃ┌ゲデﾏWﾐデ ﾗa ﾐﾗﾐｷﾐ┗;ゲｷ┗W ヮﾗゲｷデｷ┗W ヮヴWゲゲ┌ヴW ┗Wﾐデｷﾉ;デｷﾗﾐ ふNPPVぶ ｷﾐ ゲデ;HﾉW IｴヴﾗﾐｷI 
;ﾉ┗Wﾗﾉ;ヴ ｴ┞ヮﾗ┗Wﾐデｷﾉ;デｷﾗﾐ ゲ┞ﾐSヴﾗﾏWゲく J Cﾉｷﾐ SﾉWWヮ MWSく ヲヰヱヰきヶふヵぶぎヴΓヱにヵヰΓく  
ΑΑく  Cｴ;デ┘ｷﾐ Mが Tﾗ┌ゲゲ;ｷﾐデ Mが GﾗﾐN;ﾉ┗Wゲ MRが SｴWWヴゲ Nが MWﾉﾉｷWゲ Uが Gﾗﾐ┣;ﾉWゲどBWヴﾏWﾃﾗ Jが Wデ ;ﾉく 
 
 
Aｷヴ┘;┞ IﾉW;ヴ;ﾐIW デWIｴﾐｷケ┌Wゲ ｷﾐ ﾐW┌ヴﾗﾏ┌ゲI┌ﾉ;ヴ SｷゲﾗヴSWヴゲぎ A ゲデ;デW ﾗa デｴW ;ヴデ ヴW┗ｷW┘く RWゲヮｷヴ 
MWS ぷIﾐデWヴﾐWデへく ヲヰヱΒきヱンヶぎΓΒにヱヱヰく A┗;ｷﾉ;HﾉW aヴﾗﾏぎ 
ｴデデヮゲぎっっSﾗｷくﾗヴｪっヱヰくヱヰヱヶっﾃくヴﾏWSくヲヰヱΒくヰヱくヰヱヲ 
ΑΒく  J;ﾐゲゲWﾐゲ JどPが BﾗヴWﾉ JどCが PYヮｷﾐ JどLく NﾗIデ┌ヴﾐ;ﾉ ﾏﾗﾐｷデﾗヴｷﾐｪ ﾗa ｴﾗﾏW ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐぎ デｴW 
IﾗﾐデヴｷH┌デｷﾗﾐ ﾗa ゲｷﾏヮﾉW デﾗﾗﾉゲ ゲ┌Iｴ ;ゲ ヮ┌ﾉゲW ﾗ┝ｷﾏWデヴ┞が I;ヮﾐﾗｪヴ;ヮｴ┞が H┌ｷﾉデどｷﾐ ┗Wﾐデｷﾉ;デﾗヴ ゲﾗaデ┘;ヴW 
;ﾐS ;┌デﾗﾐﾗﾏｷI ﾏ;ヴﾆWヴゲ ﾗa ゲﾉWWヮ aヴ;ｪﾏWﾐデ;デｷﾗﾐく Tｴﾗヴ;┝く ヲヰヱヱ M;┞ ヱきヶヶふヵぶぎヴンΒにヴヵく  
ΑΓく  Fﾗ┝ Nが HｷヴゲIｴどAﾉﾉWﾐ AJが GﾗﾗSaWﾉﾉﾗ┘ Eが WWﾐﾐWヴ Jが FﾉWWデｴ;ﾏ Jが R┞;ﾐ CFが Wデ ;ﾉく TｴW ｷﾏヮ;Iデ ﾗa ; 
デWﾉWﾏWSｷIｷﾐW ﾏﾗﾐｷデﾗヴｷﾐｪ ゲ┞ゲデWﾏ ﾗﾐ ヮﾗゲｷデｷ┗W ;ｷヴ┘;┞ ヮヴWゲゲ┌ヴW ;SｴWヴWﾐIW ｷﾐ ヮ;デｷWﾐデゲ ┘ｷデｴ 
ﾗHゲデヴ┌Iデｷ┗W ゲﾉWWヮ ;ヮﾐW;ぎ ; ヴ;ﾐSﾗﾏｷ┣WS IﾗﾐデヴﾗﾉﾉWS デヴｷ;ﾉく SﾉWWヮく ヲヰヱヲきンヵふヴぶぎヴΑΑにΒヱく  
Βヰく  HﾗHゲﾗﾐ E Vが B;ｷヴS WOが CﾗﾗヮWヴ CLが M;┘ゲﾗﾐ Sが Sｴ;┘ PJが MISWヴﾏﾗデデ CJく Uゲｷﾐｪ デWIｴﾐﾗﾉﾗｪ┞ デﾗ 
ｷﾏヮヴﾗ┗W ;IIWゲゲ デﾗ ゲヮWIｷ;ﾉｷゲデ I;ヴW ｷﾐ ;ﾏ┞ﾗデヴﾗヮｴｷI ﾉ;デWヴ;ﾉ ゲIﾉWヴﾗゲｷゲぎ A ゲ┞ゲデWﾏ;デｷI ヴW┗ｷW┘く 
Aﾏ┞ﾗデヴﾗヮｴ L;デWヴ;ﾉ SIﾉWヴ FヴﾗﾐデﾗデWﾏヮﾗヴ;ﾉ DWｪWﾐWヴく ヲヰヱヶきヱΑふヵにヶぶぎンヱンにヲヴく  
Βヱく  Vﾗﾉヮ;デﾗ Eが B;ﾐaｷ Pが P;ｪﾐｷﾐｷ Fく A ヮゲ┞IｴﾗﾉﾗｪｷI;ﾉ ｷﾐデWヴ┗Wﾐデｷﾗﾐ デﾗ ヮヴﾗﾏﾗデW ;IIWヮデ;ﾐIW ;ﾐS 
;SｴWヴWﾐIW デﾗ ﾐﾗﾐどｷﾐ┗;ゲｷ┗W ┗Wﾐデｷﾉ;デｷﾗﾐ ｷﾐ ヮWﾗヮﾉW ┘ｷデｴ IｴヴﾗﾐｷI ﾗHゲデヴ┌Iデｷ┗W ヮ┌ﾉﾏﾗﾐ;ヴ┞ SｷゲW;ゲWぎ 
ゲデ┌S┞ ヮヴﾗデﾗIﾗﾉ ﾗa ; ヴ;ﾐSﾗﾏｷゲWS IﾗﾐデヴﾗﾉﾉWS デヴｷ;ﾉく Tヴｷ;ﾉゲく ヲヰヱΑきヱΒふヱぶぎヵΓく  
 
